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ABSTRACT
Building reliable genetic devices in synthetic biology is still a major challenge despite
the various advances that have been made in the field since its inception. In principle,
genetic devices with matching input and output expression levels can be assembled
from well-characterized genetic parts. In practice, a priori genetic circuit design con-
tinues to be difficult in synthetic biology due to the lack of foundational work in this
area. Currently, a successful genetic device is typically created by manually building
and testing many combinatorial variants of the target device and then picking the
best one. While this process is slow and error-prone, as synthetic genetic devices
grow in complexity, this approach also becomes unmanageable and impractical.
Fluctuations in genetic context have been identified as a major cause of rational
genetic circuit design failures. Promoter elements often behave unpredictably as
they are moved from the context in which they were originally characterized. Thus,
the ordered location of parts in a synthetic device impacts expected performance.
vi
Synthetic spacer DNA sequences have been reported to successfully buffer promoters
from their neighboring DNA sequence but design rules for these sequences are lacking.
I address this problem with a novel method based on a randomized insulator
library. I have developed a high-throughput, flow cytometry-based screen that ran-
domly samples from a library of 436 potential insulators created in a single cloning
step. This method provides precise control over genetic circuit expression. I fur-
ther show that insulating the promoters in a genetic NOT-gate improves circuit
performance and nearly eliminates the effect of the order in which the promoters
are organized in the device. This foundational work will help improve the design of
reliable genetic devices in E. coli.
Finally, automated DNA assembly using liquid-handling robots can help increase
the speed at which combinatorial synthetic device variants are assembled. However,
these systems require significant investment in optimizing the handling parameters
for handling very small volumes of the various liquids in DNA assembly protocols.
I have optimized and validated these liquid-handling parameters on the Tecan EVO
liquid handling robotic platform. These materials have been made available to the
larger community.
vii
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Chapter 1
Introduction
Synthetic biology holds the potential to alter the way humans interact with their
environment, providing customized genetic solutions to fields ranging from bioreme-
diation, fuel generation and fabric production all the way to personalized medical
diagnostics and treatment. Through the application of principles from engineering
disciplines, synthetic biology aims to transform biology into a systematic and pre-
dictable discipline that allows users to take genetic parts from diverse sources from
off-the-shelf kits, mix and match them using the knowledge contained within part
datasheets and then assemble them into novel, functioning genetic networks without
having to go through laborious trial and error design and assembly cycles.
While genetic parts are modular in principle, meaning they can by swapped in
and out of genetic circuits to alter circuit behavior, being composed of DNA that is
at the same time the building material for genetic parts and the chemical code that
controls part behavior, genetic parts are also sensitive to changes in DNA sequence
composition at their boundaries. Swapping genetic parts in and out can alter the
local chemistry at part junctions, or alter the distance between critical regulatory
regions where proteins such as RNA polymerase or ribosomes bind. Although rare,
there is the possibility that in fusing two genetic parts, a new part is created at
the part:part junction that has a deleterious effect on circuit performance. These
2complications pose challenges to rational genetic circuit design in spite of detailed
component part characterization data being available. Successful genetic circuits are
often arrived at by brute force: synthetic biologists are relying heavily on exhaustive
assembly and testing of all combinatorial variants of a genetic circuit, from which the
best performing one is selected [71]. This design strategy is slower and impractical
for scaling up in size and complexity [58]. So, while synthetic biology has the po-
tential to deliver solutions to a multitude of real-world problems, in order to deliver
on its promises, synthetic biology must deliver cost-effective alternatives to current
technologies in order to be commercially viable options.
The contribution of part-junction interference due to altered DNA sequence con-
text at part boundaries has now been adequately documented and is widely accepted
as a leading cause of failed a priori circuit design [13, 11]. While early synthetic bi-
ology focused heavily on making large numbers of genetic parts from diverse sources
available to encode new behaviors and provide control over expression levels, the
focus now is shifting towards making genetic parts truly modular. Novel strategies
using the latest technologies have been developed and new part collections have been
made available to remove the context dependence of Ribosome Binding Sites (RBSs)
at both the RBS:promoter and RBS:gene boundaries in bacterial genetic circuits
[50, 45, 59]. Although the effect of fluctuating DNA sequence at the 5’ boundary
of bacterial promoters is recognized, much less effort has been devoted towards re-
moving these effects, possibly because the DNA sequence immediately upstream of
a genetic circuit is not technically a part of the engineered circuit and contains no
active genetic elements.
Genetic devices are typically assembled by combining component parts together
in the order in which the genetic logic is executed. In higher-level devices composed of
3intermediate expression modules, fusing modules creates new part:part junctions that
did not exist in the original context in which component parts were characterized.
In the past few years, synthetic biologists have been paying a closer attention to the
effect of these part junction DNA sequence fluctuations and their effect on overall
circuit performance.
The ability of certain DNA sequences approximately 40 to 100 bases upstream of
the transcription start site (TSS) to increase the rate of transcription from a promoter
has been known for years [21, 47]. More recently, the strong, and extremely variable
effect of altered DNA sequences at the immediate 5’ boundary of promoters has been
documented [38].
We have also observed, however, that due to unexpected effects of DNA context
at the 5’ boundaries of promoters, an alternative configuration of a complex device
can function where the version assembled conventionally fails entirely. Assembling
and testing all possible permutations of a genetic device is a cumbersome endeavor,
and is rarely done in practice. Moreover, due to part-junction interference, a pro-
moter rationally selected for a device based on its available characterization data
may behave differently when placed into a device with different DNA bases at its 5’
boundary. Thus far, fusing mostly arbitrarily selected, synthetic insulator sequences
to the 5’ ends of promoters is the only available solution to part-junction interference
due to genetic context fluctuations at the upstream boundaries of bacterial promot-
ers. Their use is far from widespread, which may be because of a combination of the
paucity of well-characterized insulated promoter parts, and the fact that insulator
elements being themselves composed of DNA, could - and most likely would - them-
selves cause fluctuations in promoter performance that have not been characterized
and therefore cannot be modeled. Scanning prior work [16] revealed that there were
4not enough instances of insulated promoters in bacterial genetic circuits to develop
a set of rules for designing reliable insulators. Only a single length of DNA spacer
was tested, and the goal of insulation in that work was to buffer the promoter part
from DNA sequences -40 to -60 base pairs upstream of the transcription start site.
The work presented in this thesis studies DNA spacers as a tool to buffer promoters
against DNA sequence changes at the 5’ junctions of promoters.
Chapter 4 begins with a depiction of how part-junction interference at the 5’
boundary of promoters leads to dependence on the order of component transcrip-
tion units (TUs) on circuit performance. As my design, I chose a 4-TU inverter
circuit regulated entirely in trans, and created all possible tandem permutations of
the 4 component TUs to create 24 inverters that are equivalent in design. I then
demonstrate my preliminary attempt to determine the optimal length and design
characteristics of DNA spacer elements for insulating bacterial promoters from the
4 bp cloning scars present at the 5’ promoter boundary as a result of DNA assem-
bly using the Type IIS restriction endonuclease-based, Modular Cloning (MoClo).
As the addition of a stretch of DNA sequence would serve primarily to add spac-
ing between the promoter and the upstream MoClo assembly scar that we knew to
be causing fluctuations in expression, I refer to these elements in the body of this
work as DNA spacers rather than as DNA insulators to make the distinction that
they lack specific insulating properties present in eukaryotic transcriptional machin-
ery in which insulators naturally function. I investigate 3 lengths - 12nt, 24nt and
36nt - of DNA spacers upstream of 4 commonly used promoters, 3 of which are
constitutive minimal while the fourth is a repressible promoter. The selected DNA
spacer sequences were randomized sequences with no stable secondary structures or
protein-binding consensus sequences. Additionally, their DNA base composition fell
5within the accepted GC% of the intergenic regions between E. coli operons. Finding
that 36nt DNA spacers appear to reliably insulate two of the four tested promoters
(both of which are present in my inverter circuit mentioned above), while the 12nt
and 24nt DNA spacers did not, I proceeded to expand my DNA spacer library so
that I could ultimately create a library of insulated promoter parts that could be
added to public part repositories for common use. However, the expression of the
expanded insulated promoter library fluctuated from one DNA spacer to the next.
Moreover, I found these DNA spacers to be ineffective in insulating the promoters in
my abovementioned inverter circuit to remove upstream sequence-based component
order dependence.
What was needed then, was a new methodology that would allow me to screen
potential DNA spacer sequence candidates and select ones that actually served as
insulators and/or spacers: sequences that either create enough space between the
promoter and potentially problematic DNA sequences upstream, or, when inserted
upstream of a promoter that is already within the final context of DNA sequence in
which it must function, corrects whatever DNA sequence-based performance varia-
tions that have arisen due to reorganization of the promoter into a new surrounding
DNA sequence. I then present the data obtained through the high-throughput screen-
ing of the insulated promoter libraries. Sticking with the 36nt length of DNA spacer
that provided partial success in the preliminary work, to facilitate rapid insulated
promoter generation, I developed an inverse PCR-based method that would create
a library of potentially 436 insulated promoters in a single cloning step using consti-
tutive promoter J23100 that I had successfully insulated in my preliminary work in
Chapter 4.
In Chapter 5, I employ a novel, high throughput, flow cytometry-based screening
6method in which candidate insulated promoter cassette expression was compared
against a reference device of known expression level or desired expression level. I
also demonstrate the application of my screening method on an inducible promoter
(pBAD) and a repressible promoter (pTet) promoter The strength of my novel DNA
spacer screening method is that it allows one to screen for a DNA spacer that provides
precise expression control empirically in the desired DNA sequence context without
the need for additional modeling. I also show that my DNA spacer screening method
can be applied to inducible and repressible promoters.
In Chapter 6, I validate the utility of my method in the ultimate goals of elimi-
nating variations in promoter expression due to part-junction interference at the 5’
boundaries of promoters in my 24 inverter permutation set. I do this by showing that
the incremental application of my method to context-affected promoters eliminates
order dependence and improves overall performance. Finally, I apply my method to
an unaffected promoter to further improve the overall device performance of my 24
inverter permutations.
When the goal is not to perfect the expression of a single device, but instead
to produce large numbers of variations on a circuit, possibly for the creation of a
library, it is more suitable to perform combinatorial DNA synthesis. Automated
DNA assembly using liquid-handling robots is an efficient way to do this. However,
outside of commercial ventures, DNA synthesis is mostly done manually. Although
this is partly due to the relatively higher cost of liquid-handling robotics setup as
well as higher cost of resources/reaction, automated DNA synthesis suffers from the
lack of defined parameters for handling the very small volumes of liquids of various
viscosities (especially enzymes). Automated single-reaction scale DNA assembly on
liquid-handling platforms is inefficient when it works at all. In Chapter 6, I outline the
7liquid-handling parameters for aspirating and dispensing 2µL volumes of enzymes,
water. These parameters provide >99% efficiency of DNA assembly using the MoClo
DNA assembly technique. These parameters were arrived at through extensive trial
and error; all parameters were tested by calculating the number of true positive
colonies in the automated construction of a constitutive GFP expression cassette
(with manual assembly as a control at each step). Deviations from these parameters
result in 0-1% cloning efficiency. I verify that the liquid handling parameters can be
successfully applied to create 16 single MoClo transcription units from basic MoClo
parts.
My contributions to the field of synthetic biology are as follows:
1. I have developed and verified a novel method for eliminating DNA sequence
based context effects at bacterial promoters that will reduce the reliance on
trial and error in the assembly of functioning genetic circuits.
2. I have applied that method to a constitutive promoter, an inducible promoter,
and a repressible promoter.
3. Using my insulated promoters, I have eliminated component order dependence
of transcription units within a higher level genetic circuit
4. I have deposited 3 new upstream genetic context-proof promoter elements to
the standardized part repository, Addgene (and will also be adding them to
the Registry of Standard Biological Parts).
5. I have developed a set of liquid-handling parameters for automated DNA as-
sembly on a Tecan liquid-handling robotic platform that will enable automated
DNA synthesis without the addition of additional expensive robotic attach-
ments to pipettors.
Chapter 2
Background Information
2.1 Synthetic biology: definition and goals
Over the years, synthetic biology has represented a broad spectrum of endeavors
involving the modification of naturally occurring biological systems. Synthetic biol-
ogy has encompassed anything from the design of enzymes and in vitro systems, to
the decoupling of native regulation of environmentally stimulated promoters to allow
greater control over their regulation and all the way to creating entirely synthetic
replicating life forms, each of which requires genetic manipulation. However, what
sets modern synthetic biology apart from traditional genetic engineering is the ap-
plication of engineering principles like abstraction, standardization, modularity and
predictive modeling to the process of bioengineering.
Much of synthetic biology research today aims to transform biology into a sys-
tematic, predictable engineering discipline. Synthetic biology of today is often un-
derstood as the application of engineering principles to biology with the aim of
encoding natural systems and their components with novel, programmable behav-
iors. Applying such principles, naturally occurring logical expressions from one or
multiple organisms are reorganized and recombined to specify new, artificial ones.
To achieve these ends, synthetic biologists often design new genetic parts, in vitro
expression systems, biological and non-biological platforms for testing engineered ge-
9netic circuits, predictive models for evaluating component choices for genetic circuit
design, programming languages to convert logical expression specifications into valid
biological circuitry, develop new DNA assembly techniques for rapid, combinatorial
DNA assembly as well as computational tools for planning complicated assemblies
and finally establish metrology guidelines for evaluating the performance of engi-
neered genetic circuits. In doing so, synthetic biologists also seek to gain a deeper,
more fine-grained understanding of the principles guiding the rewiring of the genetic
components to make all the above processes more accurate and efficient.
2.2 Modern synthetic biology vs. traditional genetic engi-
neering
For much of its history, biology and engineering occupied largely separate realms
within the world of scientific inquiry with little, if any, overlap. Biology had to be
accepted and understood while engineering created and controlled. The perplex-
ing complexity of biological systems, both within a single system, and as present
throughout the phylogenetic tree, defied the controlled organization of engineered
devices. Both disciplines thrived on their own separate trajectories.
In the past 60 years, scientists have made enormous advances in biology, partic-
ularly in molecular biology, and have succeeded in breaking down the vast stretches
of chemically monotonous DNA molecules into many smaller defined, modular units,
specifying their boundaries, describing their characteristics, and mapping them to
specific functions. In 1961, Jacob and Monod published their work on the lac operon
describing how bacteria use transcription to regulate their behavior in response to
an external signal (lactose) [39]. Descriptions of other transcriptional regulation
networks soon followed. The discovery of the tools of genetic engineering restric-
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tion endonucleases and DNA ligase enabled Herbert Boyer and Stanley Cohen in
1973 to create the first ever recombinant DNA molecule in the laboratory. Since
then, molecular biologists have been engineering biology at the lab bench: In 1973 a
mouse was genetically modified animal (a mouse) by inserting DNA from the Simian
Virus 40 (SV40) into an early stage mouse embryo and showing that the viral DNA
was present in every cell of the adult mouse. Since then, genetic engineering has
flourished giving birth to the biotechnology industry where microbes are used as
protein factories for the production of insulin, growth hormone, or clotting factors in
the medical world, for modifying crops to make them more nutritious (golden rice),
or more pest-resistant or drought resistant, and for the commercial production of
enzymes (alpha-amylase, chymosin etc.).
However, most traditional genetic engineering efforts and achievements involve
only the insertion of one or a few genes within existing natural genetic frameworks
in order to achieve upregulation of their protein products [58]. Modularity in biol-
ogy was under-utilized. Synthetic biology recognizes the modularity in biology at
all layers of biological hierarchy, from basic genetic parts all the way to the level
of biological pathways. Coupled with abstraction of function between layers, syn-
thetic biology aims to reorganize the syntax of genetic machinery to encode entirely
new cellular outcomes. Furthermore, synthetic biology attempts to change the ad
hoc nature of bioengineering design and replace it instead with an off-the-shelf ge-
netic parts toolkit and clear design principles that eliminate the guesswork and the
mystique behind engineering biology.
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2.3 Top-down vs. bottom-up synthetic biology
Synthetic biology can often be viewed in terms of top-down and bottom-up ap-
proaches to engineering biology. The top-down approach seeks to identify the mini-
mum complement of genes required for survival, then strip down the living system of
all redundancies. Synthetic biologists have redesigned the bacteriophage T7 genome
by replacing almost 30% of its natural genetic elements with engineered DNA. In
2008, the first completely chemically assembled genome was reported [27], and was
subsequently used as the only genetic material inside a fully synthetic bacterial cell
[28]. The Craig Venter Institute has successfully identified the essential genes in
Mycoplasma genitalium [29, 33]. Another group reduced the genome of E. coli K-12
by as much as 15% and found the resulting genome-reduced E. coli to possess higher
electroporation efficiency and to accurately propagate recombinant DNA that was
found to be unstable in other E. coli strains [57]. Forster et al are building a min-
imal cell that contains its own replication and essential biochemical pathways, but
requires only small molecule nutrients for its survival [23]. More recently, in 2014,
scientists at Johns Hopkins University have created a synthetic, truncated version of
the Saccharomyces cerevisiae chromosome III and showed it to be fully functional in
yeast [5].
The construction of artificial genetic circuits from scratch with basic elements
can be considered the bottom up approach to synthetic biology. This approach uses
our current understanding of genetic circuitry to remove parts from their native
circuitry (decoupling) and re-purpose them, or to use synthetic part libraries. In the
bottom-up approach, synthetic biologists design and construct new biological parts,
which are used to build genetic circuits. These circuits link sensing an external
stimulus with the execution of engineered logic (digital or analog) with a measurable
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output. Making synthetic genetic circuits and devices de novo from basic parts
enables synthetic biologists to better understand the rules that govern circuit design
and composition. The bulk of synthetic biology research being done is bottom up
synthetic biology.
The work presented in this thesis focuses on bottom-up synthetic biology.
2.3.1 Engineering principles in synthetic biology and an analogy to com-
puter engineering
Figure 2.1: Computer engineering-inspired hierarchy analogy for biological
organization. Andrianantoandro et al. drew parallels between the organization of
electronic components in a hierarchy of increasing complexity to form systems and
then networks and genetic parts and the complex regulatory networks and biological
systems that are formed by their organization. Figure reprinted from Synthetic
biology: new engineering rules for an emerging discipline, by Andrianantoandro et
al., Molecular Systems Biology, 2006. [4]
Using the concept of modularity and abstraction, Andrianantoandro et al.[4],
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demonstrate synthetic biology as analogous to electrical and computer engineering
in its hierarchical organization: proteins and genes form the bottom-most layer of the
hierarchy analogous to the physical layer of components such as capacitors, resistors
etc., in electrical engineering. Just as the physical layer of components can be com-
bined to form logic gates, genetic regulatory elements and protein coding sequences
can be organized to produce genetic circuit that carry out biochemical reactions.
In electrical engineering, modules are created by combining and layering individual
logic gates; similarly, the output of individual biochemical reaction-producing genetic
circuits can be layered by having the output of one feed into another as its input and
to create pathways. Just as a computer contains multiple modules, cells contains
multiple pathways. Computers themselves can be connected to each other to form
networks. Similarly, cells are organized to communicate with each other as part of
tissues in multicellular organisms. Complexity in biology arises when modules at
various layers interact with each other [2], but are handled through decoupling and
abstraction.
Simplifying biological systems into modular abstracted layers allows synthetic bi-
ologists to investigate, through bottom-up construction, biology from its very first
principles. The bulk of synthetic biology research done today is the design, construc-
tion and testing of bottom-up synthetic genetic circuits.
2.4 Genetic Context in Synthetic Biology
While borrowing analogies from other engineering disciplines has been beneficial to
the development of the synthetic biology paradigm, engineering analogies do not
transfer to biology perfectly. The majority of engineered genetic circuits fail to
behave according to predictions in spite of rigorous modeling of performance based
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on extensive characterization of component parts and modules [45, 13]. This often
leads to a breakdown in rational iterative design in favor an exhaustive, resource-
intensive approach of combinatorial synthesis of all variants of a target genetic device.
Often a genetic circuit that is found to perform as expected in one host organism
(chassis) fails to express at all when transferred to a different host organism.
Unlike electrical and computer systems, biological systems are complex, in con-
stant flux and frequently not orthogonal to the component parts within the synthetic
genetic circuit. Even the most well-studied host organism, E. coli, is not fully under-
stood, and much of its biochemistry is not within the synthetic biologists’ control.
Furthermore, the synthetic circuit being tested can place strains on the host organ-
isms’ growth. The synthetic circuits themselves utilize host resources, and often the
components of synthetic circuits are also part of the host genetic machinery. In both
cases, it becomes difficult to determine the effect of the host on the performance
of the genetic circuit. The physical composition of component parts into genetic
circuits also alters genetic context at the part junctions, leading to unexpected and
unpredictable part and device expression in the final context.
2.4.1 Compositional context as a source of circuit performance failures
At the circuit level, a fundamental mechanism of controlling circuit behavior is by
swapping genetic regulatory elements such as promoters and RBSs to achieve fine
control of expression. Altering the promoter:RBS pair or the RBS:gene pair alters
the DNA sequence at part:part junctions, which has been found to sometimes and un-
expectedly impact how a part functions, resulting in a type of compositional genetic
context effect known as part-junction interference [13, 11]. Complex, multi-layered
genetic devices can be created by connecting the output of one circuit to the input
15
of the next [49]. Each connection creates new part-part junctions that are potential
sites for unexpected genetic context effects that alter circuit behavior.
Compositional context arising from part-junction interference is one of the leading
causes of a priori circuit design. Part-junction interference undermines the funda-
mental principle of composability of independently characterized genetic parts and
part modules into predictably behaving larger genetic devices, as well as restricting
the utility of characterization information of genetic parts in part repositories.
2.4.1.1 Promoter context
Promoters in particular have been reported to be sensitive to changes in DNA se-
quence at both their 5’ and 3’ sequence boundaries. Altering the DNA sequence at
the promoter:RBS junction can change the transcription start site [41, 67], which in
turn can alter the length and sequence of the 5’ untranslated region (UTR), affect-
ing promoter melting and polymerase escape frequency [16]. Cleaving the 5’ UTR
to standardize RBS accessibility via ribozymes [45] or CRISPR processing [59], or
promoter:RBS junctions using insulated RBS parts have all proven to be effective
strategies for eliminating local context effects 3’ of the promoter in bacterial systems
[50].
Short promoter parts (<50 bp) have been reported to be susceptible to altered
local context upstream of the promoter elements [3, 43, 64, 40, 32, 32, 46]. The α-
domain of RNA polymerase (RNAP) can contact the DNA sequence approximately
100 bp upstream of the promoter [51] and alter its activity.
A recent study found that a 4 bp sequence immediately upstream of the -35
RNAP binding site of bacterial minimal constitutive promoters can alter promoter
expression by up to 13x [38]. Synthetic insulator sequences have been shown to
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relieve some local compositional context effects by standardizing DNA sequence at
the 5’ boundary of the promoter [16, 25]. One study created a small library of insu-
lated minimal bacterial promoters using a single insulator sequence [16]. However,
I show in this thesis that rationally designed insulators of similar base composition
themselves alter promoter expression variably and cannot be reliably used without
being extensively characterized (See Results section in Chapter 4). Furthermore,
long-range and off-target effects of an insulator DNA sequence on other parts within
a larger genetic device cannot be predicted.
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Figure 2.2: Changing 4 base pairs at the 5 boundary of promoters alters
promoter expression. Changing the 4 base pair scar at the 5’ boundary of a given
transcription unit influences expression likely due to the proximity of the 5 fusion
site to the minimal 35 bp promoter used in this study. The colored circles A and E
represent the 4 base pair scars 5-GGAG-3 and 5-GCTT-3, respectively. Fluorescence
measurements are shown in Molecules of Equivalent Fluorescein (MEFLs). Figure
reprinted with permission from CIDAR MoClo: Improved MoClo Assembly Standard
and New E. coli Part Library Enable Rapid Combinatorial Design for Synthetic and
Traditional Biology, by S Iverson et al., ACS Synthetic Biology, 2016 [38].
Chapter 3
Materials and Methods
3.1 Materials
3.1.1 Media
The media used for growing the bacteria strains in this study are shown in Table 3.1
below. All media were autoclaved (121 C for 15 minutes) or filter-sterilized (0.22 µm
filter) prior to use.
Table 3.1: Bacterial growth media used in this study
Medium Vendor Used for
Luria Bertani (LB) Broth (Lennox) Sigma-Aldrich General growth in liquid media
LB Broth with Agar (Lennox) Sigma-Aldrich General growth in solid media
SOC Broth Sigma-Aldrich Post-transformation recovery
L-Arabinose Sigma-Aldrich Small molecule inducer
3.1.2 Bacterial strains
All transformation and flow cytometry assays were performed in Alpha Select Gold
Efficiency E. coli cells (Bioline USA Inc., Tauton, MA, USA) (Genotype: F- deoR
endA1 recA1 relA1 gyrA96 hsdR17(rk-, mk+) supE44 thi-1 phoA ∆(lacZYA-argF)U169
φ80lacZ∆M15 λ-). α-Select Gold cells are directly comparable to DH5α cells. They
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contain a lacZ marker that provides α-complementation of the β-galactosidase gene
for blue/white color screening.
Bacterial strains were streaked for single colonies from glycerol stocks onto solid
agar media and grown overnight at 37◦. Liquid cultures (see section 3.3) were inoc-
ulated with single bacterial colonies and grown overnight at 37◦ with shaking (300
rpm)
3.1.3 Antibiotics
The final (1x) concentrations of antibiotics used for selective growth of E. coli in
both solid and liquid media in this study are listed in Table 3.2 below.
Table 3.2: Antibiotics used in this study. Relevant antibiotics were added to all
bacterial growth media in 1x concentration.
Antibiotic Final Concentration Vendor
Ampicillin 100 µg/mL Zymo Research
Kanamycin 35 µg/mL Zymo Research
Chloramphenicol 25 µg/mL Zymo Research
3.1.4 Kits
Commercially available kits as available from vendors listed below in Table 3.3 were
used in this study as per manufacturer’s protocols.
3.1.5 Enzymes
The enzymes used in this study are described in Table 3.4. All enzymes were pur-
chased either from New England BioLabs (Ipswich, MA, USA) or Promega Corp.
(Madison, WI, USA).
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Table 3.3: Molecular kits used in this study. Miniprep and maxiprep kits were
used to purify DNA for sequence verification or for use in downstream DNA assembly
reactions. PCR cleanup kits were used to remove PCR reagents and oligonucleotide
primers from reactions before using in downstream DNA assembly steps.
Kit Company Used for
QIAprep Spin Miniprep Kit Qiagen
Purification of
plasmid DNA
GenCatch Plasmid DNA Mini-Prep Kit Epoch Life Science
Purification of
plasmid DNA
NucleoBond Xtra Midi Plus Machery-Nagel
Purification of
plasmid DNA
QIAquick PCR Purification Kit Qiagen
Purification of
PCR product
GenCatch PCR Cleanup Kit Epoch Life Science
Purification of
PCR product
QIAquick Gel Extraction Kit Qiagen
Purification of DNA
from agarose gel
GenCatch Gel Extraction Kit Epoch Life Science
Purification of DNA
from agarose gel
3.1.6 DNA parts and primers
The following basic DNA parts in 3.5 were taken from the CIDAR Inventory of Com-
posable Elements (ICE) Registry [56] and available from Addgene [1]( # 1000000059)
for use in the assembly of some of the higher level circuits in this study. Rationally
insulated promoter parts and promoter parts insulated using our new custom DNA
spacer generation and screening method were synthesized as gblocks from Integrated
DNA Technologies (Coralville, Iowa, USA). Rationally and empirically (using new
screening technique) insulated promoter parts that were used to create Level 1 MoClo
circuits and Level 2 inverter devices are listed in Table 3.8 and Table 3.9, respectively.
All primers for sequencing and creating randomized insulated promoter libraries
are listed in Table 3.11 and Table 3.10, respectively. Primers VF and/or VR were
used to sequence all intermediate inverter MoClo Level 1 circuits and to run colony
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Table 3.4: Enzymes used in this study. BsaI was used to construct Level 1 genetic
circuits from basic (Level 0) parts. BbsI was used to construct Level 2 MoClo circuits
from Level 1 circuits. Restriction digests were performed to verify genetic circuit size
or to move a circuit into a different vector backbone. DpnI was used in the creation
of insulated promoter libraries as described in section 3.2.3.1
Enzyme Vendor Application
BsaI New England BioLabs MoClo DNA Assembly
BbsI New England BioLabs MoClo DNA Assembly
T4 Ligase Promega MoClo DNA Assembly
T4 Ligase New England BioLabs Ligation
EcoRI New England BioLabs Restriction Digestion
XbaI New England BioLabs Restriction Digestion
SpeI New England BioLabs Restriction Digestion
PstI New England BioLabs Restriction Digestion
DpnI New England BioLabs Removing PCR template DNA
PCRs (Section 3.2.4). Full inverters were sequence-verified with sequencing primers
designed to AraC, TetR, GFP and RFP CDSs as listed in Table 3.10.
3.2 Methods
3.2.1 DNA purification
Plasmid DNA were purified from target bacterial cells grown in a 5 mL overnight
LB culture supplemented with the appropriate antibiotic using the QIAprep Spin
Miniprep kit (Qiagen), GenCatch Plasmid DNA Mini-prep kit (Epoch Life Science)
or NucleoBond Xtra Midi Plus kit (Macherey-Nagel) according to the manufacturers
instructions. The plasmids were eluted in a final volume of 50 µL of GenCatch Elu-
tion Buffer (10 mM Tris-Cl, pH 8.5) for mini-prep protocols and in 300µL GenCatch
Elution Buffer for midi-prep protocols.
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3.2.2 Modular Cloning (MoClo) DNA assembly
An updated and optimized protocol for the single pot, multi-part, Type IIS restric-
tion endonuclease-based Modular Cloning (MoClo) DNA assembly method first de-
scribed in 2011 [68] was used to generate all MoClo Level 1 monocistronic inverter/NOT-
gate circuits in Chapters 4 and 6. All basic DNA parts (Table 3.5) were either
obtained from the CIDAR-ICE registry [56, 30] or were purchased as gblocks from
Integrated DNA Technologies (Madison, WI, USA) with the addition of DNA spacers
and 4 bp MoClo-format overhangs (fusion sites) for assembly into MoClo Level 1 cir-
cuits. Level 1 MoClo circuits were assembled into Level 2 MoClo circuits (inverters)
by standard MoClo assembly as described here [30, 38].
3.2.2.1 MoClo Level 1 part assembly from basic DNA parts in MoClo
format
A transcriptional unit (promoter::RBS::CDS::terminator) or Level 1 MoClo part can
be constructed from basic/Level 0 MoClo parts by combining equimolar amounts
(4-40 fmol) of each basic part into a Level 1 destination vector in a one pot restric-
tion digestion-ligation reaction using BsaI and T4 DNA ligase enzyme (3.4). Level
0 parts have overlapping fusion sites such that the 3’ fusion site of the upstream
part must match the 5’ fusion site of the downstream part for accurate directional
assembly. The destination vector fusion sites must match the 5’ fusion site of the
promoter and the 3’ fusion site of the terminator respectively. Level 0 parts have
either chloramphenicol or ampicillin resistance while Level 1 vectors have kanamycin
resistance and use lacZα blue-white selection. An overview of MoClo Level 1 part
assembly is schematically shown in Figure 3.1
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3.2.2.2 MoClo Level 2 part assembly from Level 1 MoClo parts
Level 2 MoClo parts (higher-level genetic devices comprising multiple MoClo mono-
cistronic transcriptional units) can be made by combining equimolar amounts of
Level 1 MoClo parts (individual transcriptional units) with an ampicillin-resistant
Level 2 destination vector in a one pot, restriction digestion-ligation reaction using
BbsI (also called BpiI) and T4 DNA ligase (Table 3.4). The 3’-flanking fusion site
of the first transcriptional unit must overlap with the 5’-flanking fusion site of the
second transcriptional unit etc., for accurate directional assembly. Level 2 MoClo
reactions also use lacZα blue-white selection. An overview of MoClo Level 1 part
assembly is schematically shown in Figure 3.1
3.2.2.3 Modular Cloning (MoClo) Reaction Parameters and reaction
protocol:
Each of 4 DNA parts (Level 0 parts for Level 1 MoClo reaction, and 2-4 Level
1 MoClo parts for Level 2 MoClo reaction) along with destination vector (DVL 1
or DVL 2 for Level 1 and Level 2 MoClo reactions, respectively) with fusion sites
appropriate to insert parts (see Figures 3.1 and 3.1) were diluted to 10-20 fmol
concentrations and added in equimolar amounts to the reaction. DNA parts can be
purified plasmid DNA, PCR fragment or synthesized double-stranded DNA. DNA
parts were combined with 1x T4 DNA ligase buffer (Promega), 5 units of BsaI
(New England Biolabs) for Level 1 MoClo reaction and 10 units for Level 2 MoClo
reaction, along with 120 units of T4 DNA ligase enzyme (New England BioLabs).
The reaction was brought up to a final volume of 10 µL. MoClo reactions were
performed in an Eppendorf Mastercycler ep thermocycler (Eppendorf) using the
following parameters: 25 cycles (37◦C for 1.5 minutes, 16◦C for 3 minutes), 50◦C for
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5 minutes and 80◦ for 10 minutes. Reactions were then held at either 4◦ or -20◦ until
transformed.
3.2.3 Randomized spacer generation and screening
3.2.3.1 Randomized spacer generation
A 100% sequence-randomized, 36 bp insulated promoter library for a target MoClo
promoter was generated by performing an inverse PCR reaction using divergent
primers containing phosphorylated 18N (NNNNNNNNNNNNNNNNNN) 5’ over-
hangs using either a constitutively expressed GFP expression cassette (J23100), an
inducible GFP expression cassette (pBAD) or a repressible RFP expression cassette
(pTet) as template. PCR was followed by a blunt-end ligation followed by transfor-
mation and plating on LB agar with appropriate antibiotics.
To enable subsequent screening of insulated promoters (see Figure 3.2), the target
promoter was assembled into a GFP-expression cassette and the resulting transcirp-
tional unit (TU) was used as the PCR template. The uninsulated transcriptional
unit plasmid DNA was eliminated by overnight DpnI digestion followed by overnight
blunt-end ligation as shown in Figure 3.2.
The forward primer was designed to include (from 5’ to 3’) a 100% degenerate 18N
sequence followed by the promoter and further downstream sequence up to 44 bases.
The reverse primer was designed to include (from 5’ to 3’) a 100% degenerate 18N
sequence, followed by the MoClo fusion site immediately upstream of promoter and
further upstream sequence up to 44 bases. The primers were ordered phosphorylated
and PAGE-purified from the manufacturer (Integrated DNA Technologies, Iowa,
USA). Eight 50µL PCR reactions were set up using High Fidelity (HF) Phusion
polymerase (New England BioLabs, Ipswich, MA, USA). Reactions were set up as per
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the manufacturer’s recommended protocol. The PCR products were pooled together.
Template plasmid DNA was eliminated from the PCR product by overnight DpnI
digestion of PCR product at 37◦ followed by heat inactivation of enzyme at 80◦ for 20
minutes. DpnI digestion was carried out as outlined in Section 3.2.3.2. The digested
PCR product was purified (Table 3.3) and held at at -20◦ until ligation.
3.2.3.2 Ligation and transformation
Blunt-end ligation was performed on the purified, digested and heat-inactivated PCR
product at 16◦C overnight in an Eppendorf Mastercycler ep thermocycler (Eppen-
dorf). Ligated product was either held on ice or stored at -20◦ until ready to be
transformed. The ligated PCR product contains the fully constructed insulated pro-
moter cassette library. 5 µL of ligated insulated promoter expression cassette library
was transformed into 25 µL of E. coli Alpha Select Gold Efficiency chemically com-
petent E. coli cells (Bioline USA Inc., Tauton, MA, USA) as described in Section
3.2.5.
3.2.3.3 Randomized spacer screening
For tested promoters, spacer screening was performed using the upstream (5’) MoClo
fusion site that most affected promoter expression. Colonies from the insulated pro-
moter expression cassette library were grown overnight in LB broth with appropriate
antibiotics. Fluorescence expression for colonies were tested by flow cytometry for ei-
ther GFP (promoters J23100 and pBAD) or RFP (promoter pTet). For constitutive
promoter J23100, insulated J23100 samples with GFP expression levels identical to
the J23100-GFP A cassette were selected from the tested samples as candidates for
DNA spacers in target genetic devices. For promoter pBAD, insulated pBAD-GFP
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samples with GFP expression identical to that of pBAD-GFP A in the induced state
were selected as candidate DNA spacer sequences. For repressible promoter pTet,
insulated pTet-RFP samples demonstrating RFP repression of >10x were selected
as candidate spacer sequences.
3.2.4 Colony PCR
Fully assembled inverter devices were first checked for size by performing a colony
PCR using standard PCR reagents and VF and VR primers (Table 3.10) to check the
size of the cloned product after the MoClo Level 2 reaction ( Section 3.2.2, Figures
3.1, 3.2.2). Taq 2x MasterMix (New England BioLabs, Ipswich, MA, USA) and
0.2µM each of primers VF and VR (Table 3.10). PCR reaction was performed with
an initial denaturation step at 95◦C for 30 seconds, followed by 25 cycles each of
95◦C for 20 seconds, 61◦C for 20 seconds (primer annealing) and 68◦C for 1 minute
per kilobase of DNA in reaction (primer extension). After cycling, a final extension
of 7 minutes at 68◦C was performed. Reactions were held at 4◦C until ready to be
checked on a gel. All inverters were checked for size by electrophoresis through a
1% agarose gel using a 2-log ladder (New England BioLabs, Ipswich, MA, USA) as
molecular size markers. Inverters that were the correct size were sequenced using
sequencing primers designed to AraC, TetR, GFP and RFP CDSs (Table 3.10).
3.2.5 Transformation and selection
For transformation of MoClo reactions, 3 µL of the MoClo (Level 1 or Level2) reaction
mixture was combined with minimal handling with 7-20 µL of Alpha Select Gold
Efficiency chemically competent E. coli cells (Bioline USA Inc., Tauton, MA, USA)
that had been thawed on ice. For transformation of ligation mixture from blunt-end
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ligation for randomized insulated cassette generation, 5 µL of the ligation mixture
was combined with 25 µL of Alpha Select Gold Efficiency chemically competent E.
coli cells (Bioline USA Inc., Tauton, MA, USA) that had been thawed on ice.
The mixture was allowed to incubate on ice for 2-15 minutes before being heat
shocked in a 42◦ water bath for 30-45 seconds. The cells were recovered with 1 mL
of SOC broth for 45-60 minutes at 37◦ shaking (300 rpm) before being plated on ap-
propriate antibiotic selective LB agar plates supplemented with 80 µL of 20mg/µL 5-
bromo-4-chloro-3-indolyl β-D-galactopyranoside (X-GAL) and 100 µL of 0.1M isopropyl-
β-D-thiogalactopyranoside (IPTG) (Zymo Research Corp., Irvine, CA USA).
White colonies were selected from the overnight transformation plate and grown
overnight at 37◦ shaking in LB broth medium with appropriate antibiotic. For MoClo
reactions, plasmid DNA was purified using DNA purification using plasmid purifi-
cation kits as per manufacturer’s instructions (see Section 3.3) and sent for DNA
sequencing. For randomized spacer generation, selected colonies were screened by
flow cytometry (see Section 3.3.2).
3.2.6 DNA sequencing
For purified plasmid DNA sequencing, a 10 µL reaction was prepared containing 150-
200 ng of purified plasmid DNA, 1.67 pmol/µL sequencing primer (1 µL primer from
a 10 µM stock) and deionized water to 10 µL. The spacer library was sequenced by
submitting unpurified colony PCR samples and 10µM primer stock. All sequencing
reactions were submitted to QuintaraBio for Sanger sequencing. Sequence analysis
of trace files were performed using Benchling [60, 15].
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3.3 In vivo assay methods
3.3.1 Growth of bacterial cells
Single bacterial colonies were inoculated into culture tubes with LB broth with ap-
propriate antibiotics. Inoculated cultures were grown 14-17 hours to a density of
approximately 34 x 109 cells per mL.
3.3.2 Fluorescence measurements by flow cytometry
All fluorescent expression devices were characterized using a BD LSRFortessa SORP
flow cytometer. RFP fluorescence was measured using a solid-state Coherent Sap-
phire 561 nm laser at 100 mw strength with a PE-Texas Red 610/20 filter. GFP fluo-
rescence was measured using a solid-state Coherent Sapphire 488 nm laser at 200 mw
strength with a FITC 530/30 filter. LB agar (Sigma-Aldrich, St. Louis, MO, USA)
plates containing the appropriate antibiotic were inoculated with Alpha-Select Gold
Efficiency E. coli cells (Bioline) containing the confirmed plasmid construct/clone
from insulated promoter cassette library of interest. Colonies were grown in 200
µL LB broth (Sigma-Aldrich) with the appropriate antibiotic in sterile 96-well, deep
well plates (BioExpress, Kaysville, UT, USA) in triplicate (for confirmed plasmid
construct) or singly (for insulated promoter expression cassette library) for 14 hours
at 37◦C shaking at 300 rpm. Cells were then diluted 100-fold into 200 µL of 1x
sterile phosphate buffered saline (BioExpress) in 96-well round bottom plates before
measurement using a high-throughput sampler (HTS).
3.3.3 Molecules of Equivalent Fluorescein (MEFL) conversion
Flow cytometry data was converted from arbitrary units to compensated MEFL
(Molecules of Equivalent Fluorescein) using the TASBE characterization method
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[9, 7]. An affine compensation matrix is computed from single color, dual color, and
blank controls: RFP (red) alone (J23104:BCD2:E1010m:B0015 in the MoClo Level
1 destination vector DVL1 AE, abbreviated as pJ04B2Rm AE), GFP (green) alone
(J23104:BCD2: E0040m:B0015 in the MoClo Level 1 destination vector DVL1 AE,
abbreviated as pJ04B2Gm AE, the dual red-green color control (pJ04B2Rm:J04B2Gm)
in the MoClo destination vector DVL2 AF, abbreviated as pJ04B2Rm:J04B2Gm AF)
and untransformed Alpha Select E. coli cells (Bioline, Tauton, MA, USA), respec-
tively. FITC measurements (for GFP) are calibrated to MEFL using SpheroTech
RCP-30-5-A beads [36].
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Table 3.5: Basic MoClo DNA parts and vectors used in this study to con-
struct higher level genetic circuits. All basic parts (except B0030m BC) are
archived and publicly available through Addgene [1] and the CIDAR-ICE DNA Parts
Registry [56]. The following basic parts were used to construct higher level circuits
and devices described in this study. Insulated promoters were derived from basic
promoter parts listed below by inserting additional bases (12, 24 or 36 bp) to serve
as DNA spacers between the promoter and its 5 flanking MoClo fusion site.
Basic DNA
part name
Part Type
CIDAR-ICE
ID
Addgene
ID
J23100 AB constitutive promoter CIDAR-490 65980
J23100 EB constitutive promoter CIDAR-491 65981
J23100 FB constitutive promoter CIDAR-492 65982
J23100 GB constitutive promoter CIDAR-493 65983
pBAD AB inducible promoter CIDAR-526 66016
pBAD EB inducible promoter CIDAR-527 66017
pBAD FB inducible promoter CIDAR-528 66018
pBAD GB inducible promoter CIDAR-529 66019
pTet AB repressible promoter CIDAR-518 66008
pTet EB repressible promoter CIDAR-519 66009
pTet FB repressible promoter CIDAR-520 66010
pTet GB repressible promoter CIDAR-521 66011
B0030m BC RBS/BCD 74394
B0032m BC RBS/BCD CIDAR-530 66020
B0034m1 BC RBS/BCD CIDAR-531 66022
BCD12 BC RBS/BCD CIDAR-533 66023
E0040m CD (GFP) CDS CIDAR-542 66032
E1010m CD (RFP) CDS CIDAR-543 66033
C0040 CD (TetR) CDS CIDAR-537 66027
C0080 CD (AraC) CDS CIDAR-539 66029
B0015 DE Double terminator CIDAR-545 66035
B0015 DF Double terminator CIDAR-546 66036
B0015 DG Double terminator CIDAR-547 66037
B0015 DH Double terminator CIDAR-548 66038
DVLK AE destination vector CIDAR-577 66067
DVLK EF destination vector CIDAR-578 66068
DVLK FG destination vector CIDAR-579 66069
DVLK GH destination vector CIDAR-580 66070
DVLA AH destination vector CIDAR-553 66043
DVLA AF destination vector CIDAR-551 66041
DVLA AG destination vector CIDAR-552 66042
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Table 3.6: Promoter parts insulated with 12 bp rationally designed spacers.
Constitutive promoters J23100, J23100, J23104, inducible promoter pBAD and the
repressible promoter pTet were insulated with 12 bp spacers. DNA spacers were
placed between MoClo fusion site and immediately 5’ of promoter. Sequence is
read as MoClo 5 fusion site-Spacer-promoter-MoClo 3 fusion site. First four bases
represent upstream MoClo fusion site. DNA spacer sequence is represented in capital
letters. Promoter sequence follows spacer sequence. Final four bases represent the
MoClo 3 fusion site immediately downstream of the promoter. The sequences listed
below can also be found in the CIDAR Benchling parts collections.
Rationally Insulated Promoters Sequence
12INS1-J23100 E
gcttTCCCGAGTAAGTttgacggctag
ctcagtcctaggtacagtgctagctact
12INS2-J23100 E
gcttCATATCTCCAAAttgacggctag
ctcagtcctaggtacagtgctagctact
12INS1-J23101 E
gcttTCCCGAGTAAGTtttacagctag
ctcagtcctaggtattatgctagctact
12INS2-J23101 E
gcttCATATCTCCAAAtttacagctag
ctcagtcctaggtattatgctagctact
12INS1-J23104 E
gcttTCCCGAGTAAGTttgacagctag
ctcagtcctaggtattgtgctagctact
12INS2-J23104 E
gcttCATATCTCCAAAttgacagctag
ctcagtcctaggtattgtgctagctact
12INS1-pTet E
gcttTCCCGAGTAAGTtccctatcagtg
atagagattgacatccctatcagtgatagagatac
tgagcactact
12INS2-pTet E
gcttCATATCTCCAAAtccctatcagtg
atagagattgacatccctatcagtgatagagatac
tgagcactact
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Table 3.7: Promoter parts insulated with 24 bp spacers. Constitutive promot-
ers J23100, J23100, J23104, inducible promoter pBAD and the repressible promoter
pTet were insulated with 24 bp rationally designed spacers. DNA spacers were placed
between MoClo fusion site and immediately 5’ of promoter. Sequence is read as Mo-
Clo 5 fusion site-Spacer-promoter-MoClo 3 fusion site. First four bases represent
upstream MoClo fusion site. DNA spacer sequence is represented in capital letters.
Promoter sequence follows spacer sequence. Final four bases represent the MoClo
3 fusion site immediately downstream of the promoter. The sequences listed below
can also be found in the CIDAR Benchling parts collections.
Rationally Insulated Promoters Sequence
24INS1-J23100 E
gcttCCATTGAGCCAGCTTCAGGGTTCA
ttgacggctagctcagtcctaggtacagtgctagctact
24INS1-J23100 E
gcttGAGGTCCGTGCACCGTCAGAAGCC
ttgacggctagctcagtcctaggtacagtgctagctact
24INS1-J23101 E
gcttCCATTGAGCCAgcttCAGGGTTCA
tttacagctagctcagtcctaggtattatgctagctact
24INS1-J23101 E
gcttGAGGTCCGTGCACCGTCAGAAGCC
tttacagctagctcagtcctaggtattatgctagctact
24INS1-J23104 E
gcttCCATTGAGCCAgcttCAGGGTTCA
ttgacagctagctcagtcctaggtattgtgctagctact
24INS1-J23104 E
gcttGAGGTCCGTGCACCGTCAGAAGCC
ttgacagctagctcagtcctaggtattgtgctagctact
24INS1-R0040 E
gcttCCATTGAGCCAgcttCAGGGTTCA
tccctatcagtgatagagattgacatccctatcagtgatag
agatactgagcactact
24INS1-R0040 E
gcttGAGGTCCGTGCACCGTCAGAAGCC
tccctatcagtgatagagattgacatccctatcagtgatagag
atactgagcactact
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Table 3.8: Promoter parts insulated with 36nt spacers. 36nt DNA spacers were
placed between 5’ boundary and upstream MoClo fusion site of promoters J23100,
J23100, J23104, pBAD and pTet. First and final 4 bp represent 5’ and 3’ MoClo
fusion sites. DNA spacer sequence is in capital letters. Promoter sequence follows
spacer sequence. Final four bases represent the MoClo 3 fusion site immediately
downstream of the promoter. Table continued on following page.
Insulated Promoter Insulated Promoter Sequence
36INS1-J23100 E
gcttCCTGCAGTATTCATTTTCAGC
TTACGGAAGGTAGATttgacggctagc
tcagtcctaggtacagtgctagctact
36INS2-J23100 E
gcttAGCAGTTACTCAAGTGGTCA
GGAGGCAGACGCAGCGttgacggct
agctcagtcctaggtacagtgctagctact
36INS1-J23100 A
ggagCCTGCAGTATTCATTTTCAG
CTTACGGAAGGTAGATttgacggcta
gctcagtcctaggtacagtgctagctact
36INS2-J23100 A
ggagAGCAGTTACTCAAGTGGTC
AGGAGGCAGACGCAGCGttgacgg
ctagctcagtcctaggtacagtgctagctact
36INS3-J23100 A
ggagCCTTTTCACGAGTCGCGTAC
TCTCCTAACTATCAAGttgacggctag
ctcagtcctaggtacagtgctagctact
36INS4-J23100 A
ggagTTAATCAGTGATAAGTTAAGA
TGCAACCAGAAGGCAttgacggctagct
cagtcctaggtacagtgctagctact
36INS5-J23100 A
ggagACCCGTACCGGAGCTCAATAA
CGGTGCGGCGTTTGGttgacggctagctc
agtcctaggtacagtgctagctact
36INS6-J23100 A
ggagAAGCGTTACAGCTCTTGTCCG
TCCTAGGCAGCACTTttgacggctagctc
agtcctaggtacagtgctagctact
36INS7-J23100 A
ggagAGGGACGACCCGCGCACAGA
ATGTGTCGGGGTAACAttgacggctagc
tcagtcctaggtacagtgctagctact
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Table 3.8: Promoter parts insulated with 36nt spacers. (Table continued from
previous page.)
Insulated Promoter Insulated Promoter Sequence
36INS8-J23100 A
ggagGGGTACAAAATTAAAAACAC
AGTGATGGAACCGTCCttgacggctag
ctcagtcctaggtacagtgctagctact
36INS9-J23100 A
ggagCATCTAGTTGCGGAAAGTGTG
TCACGAGTATCACGTttgacggctagctca
gtcctaggtacagtgctagctact
36INS10-J23100 A
ggagTAGGGGGCAAACATAACTCTC
GTTCCGGGGAATGGCttgacggctagctc
agtcctaggtacagtgctagctact
36INS1-J23101 E
gcttCCTGCAGTATTCATTTTCAGCTT
ACGGAAGGTAGATtttacagctagctcagtc
ctaggtattatgctagctact
36INS2-J23101 E
gcttAGCAGTTACTCAAGTGGTCAGG
AGGCAGACGCAGCGtttacagctagctcagt
cctaggtattatgctagctact
36INS1-J23104 E
gcttCCTGCAGTATTCATTTTCAGCTTA
CGGAAGGTAGATttgacagctagctcagtcct
aggtattgtgctagctact
36INS2-J23104 E
gcttAGCAGTTACTCAAGTGGTCAGGA
GGCAGACGCAGCGttgacagctagctcagtcc
taggtattgtgctagctact
36INS1-pTet E
gcttCCTGCAGTATTCATTTTCAGCTTAC
GGAAGGTAGATtccctatcagtgatagagattgac
atccctatcagtgatagagatactgagcactact
36INS2-pTet E
gcttAGCAGTTACTCAAGTGGTCAGGAG
GCAGACGCAGCGtccctatcagtgatagagattgac
atccctatcagtgatagagatactgagcactact
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Table 3.9: List of 36nt insulated promoters used in this study.The following
promoters were created using DNA spacers selected using my screening methodol-
ogy as described in Chapter 3, Section 3.2 and are available through Addgene [1].
Insulated promoter parts will also be submitted to the Registry of Biological Parts
[35].
Insualted promoters from screen Length of DNA spacer Addgene ID
36INS1-J23100 A 36 bp 78666
36INS1-J23100 E 36 bp 78667
36INS1-J23100 F 36 bp 78668
36INS1-J23100 G 36 bp 78669
A05-36INS-pBAD A 36 bp 78670
A05-36INS-pBAD E 36 bp 78671
A05-36INS-pBAD F 36 bp 78672
A05-36INS-pBAD G 36 bp 78673
D06-36INS-pBAD A 36 bp 78674
D06-36INS-pBAD E 36 bp 78675
D06-36INS-pBAD F 36 bp 78676
D06-36INS-pBAD G 36 bp 78677
C12-36INS-pTet A 36 bp 78678
C12-36INS-pTet E 36 bp 78679
C12-36INS-pTet F 36 bp 78680
C12-36INS-pTet G 36 bp 78681
Table 3.10: List of primers used for sequencing.
Primer Name Sequence
VF tgccacctgacgtctaagaa
VR attaccgcctttgagtgagc
AraC-seq-for attcggagctgctggcgataaatct
AraC-seq-rev tgatcgctgatgtactgacaagcct
TetR-seq-for acgctaaaagttttagatgtgctttact
TetR-seq-rev tgagtgcatataatgcattctctagtg
GFP-seq-for acgtgctgaagtcaagtttgaaggt
GFP-seq-rev tgccatgatgtatacattgtgtgagt
RFP-seq-for aggtttcaaatgggaacgtgttatgaa
RFP-seq-rev ggaagttggtaccacgcagtttaact
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Table 3.11: List of primers used to generate insulated promoter libraries.
Primer Name Sequence Function
36N-pJ00B12Gm
-For
NNNNNNNNNNNNNNNNNN
ttgacggctagctcagtcctaggtacagtgct
agcTACTgggcc
36N-J23100 A
library creation
36N-pJ00B12Gm
A-Rev
NNNNNNNNNNNNNNNNNN
CTCCatgtcttccactagtctctagaagcg
gccgcgaattccag
36N-J23100 E
library creation
36N-pJ00B12Gm
E-Rev
NNNNNNNNNNNNNNNNNN
AAGCatgtcttccactagtctctagaagc
ggccgcgaattccag
36N-J23100 H
library creation
36N-pJ00B12Gm
H-Rev
NNNNNNNNNNNNNNNNNN
TAGTatgtcttccactagtctctagaagcg
gccgcgaattccag
36N-J23100 K
library creation
36N-pJ00B12Gm
K-Rev
NNNNNNNNNNNNNNNNNN
GACTatgtcttccactagtctctagaagcg
gccgcgaattccag
36N-pBAD
library creation-1
36N-pBAD-For
NNNNNNNNNNNNNNNNNN
acattgattatttgcacggcgtcacactttgct
atgccatagca
36N-pBAD
library creation-2
36N-DVL2 A-Rev
NNNNNNNNNNNNNNNNNN
CTCCtgagacccactagtctctagaagcg
gccgcgaattccaga
36N library
common reverse
primer
36N-pTet-For
NNNNNNNNNNNNNNNNNN
tccctatcagtgatagagattgacatccctatc
agtgatagaga
36N-pTet
library creation
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Figure 3.1: Construction of a Level 1 MoClo part. Four basic DNA parts (pro-
moter, RBS/5’UTR, CDS and terminator) are each shown in green vectors to denote
the chloramphenicol resistance cassette and each has two 4 bp non-palindromic fu-
sion sites flanking the DNA part (colored circles). The fifth vector is the Destination
Vector (DV) for the final construct, which is orange to denote the kanamycin resis-
tance cassette and contains the lacZ gene fragment for blue-white screening. The
BsaI sites (green text) are shown in the DNA part vectors and DV with the direction
they cut (green arrows). The 4 bp fusion sites (black text in colored circles) shown in
the five top plasmids indicate the fusion sites that will remain with either the DNA
parts or the DV after BsaI digestion. (caption continued on next page.)
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Construction of a Level 1 MoClo part. (Continued from previous page.) By al-
lowing matching fusion sites between the 3’ end of the first part and the 5’ end of the
second part, and so on, this ensures that the parts assemble in the desired assembly
order of promoter-RBS/5’-UTR/CDS-terminator. The DV fusion sites match the
fusion sites on the 5’ end of the promoter and the 3’ end of the terminator to allow
the properly assembled transcriptional unit to to be cloned into the vector in the
correct orientation. The assembled transcriptional unit replaces the lacZ fragment
and colonies containing kanamycin-resistant plasmids with assembled transcriptional
unit grow on antibiotic media with IPTG and X-GAL as white colonies, thus en-
abling blue-white screening along with antibiotic selection. Figure reproduced with
permission from Type IIS Assembly for Bacterial Transcriptional Units: A Standard-
ized Assembly Method for Building Bacterial Transcriptional Units Using the Type
IIS Restriction Enzymes BsaI and BbsI by Traci Haddock et al, 2015 from BioBricks
Foundation. [30]
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Figure 3.1: Construction of a Level 2 MoClo part. Four MoClo Level 1 parts
(see Figure 3.1) are each shown in orange vectors to denote the kanamycin resistance
cassette and each has two 4 bp non-palindromic fusion sites (colored circles) flanking
all of the DNA parts. The fifth vector is the Destination Vector (DV) for the final
construct, which is blue to denote the ampicillin resistance cassette and contains a
LacZ fragment for blue-white screening. The BbsI sites (purple text) are shown in
the DNA part vectors and the DV with the direction they cut (purple arrows). By
allowing matching fusion sites between the 3’ end of T1 and the 5’ end of P2, and
so on, the final assembled device maintains the transcriptional units in the desired
order. The assembled multi-TU device replaces the lacZ fragment and colonies con-
taining kanamycin-resistant plasmids with assembled transcriptional unit grow on
antibiotic media with IPTG and X-GAL (Section 3.2.5 as white colonies, thus en-
abling blue-white screening along with antibiotic selection. Figure reproduced with
permission from Type IIS Assembly for Bacterial Transcriptional Units: A Standard-
ized Assembly Method for Building Bacterial Transcriptional Units Using the Type
IIS Restriction Enzymes BsaI and BbsI by Traci Haddock et al, 2015 from BioBricks
Foundation. [30]
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Figure 3.2: Divergent forward and reverse primers with 18N
(NNNNNNNNNNNNNNNNNN) 5’ primer extensions were used in an inverse
PCR reaction using a plasmid containing the target genetic circuit as PCR
template. The forward primer is designed to anneal to the promoter that is to
be insulated. The reverse primer is designed to anneal to the MoClo fusion site
immediately upstream of the promoter. The PCR reaction will result in a library
of linearized plasmid DNA strands with the target promoter insulated. Overnight
DpnI digestion removes residual template DNA. The linear plasmid PCR products
are circularized in an overnight blunt-end ligation and then transformed and plated
onto LB agar with appropriate antibiotics. Colonies from the library are grown
overnight in liquid media, diluted before taking fluorescence measurements using a
flow cytometer. The fluorescence expression of a reference device is used to screen
the library of insulated expression cassettes for ones with the precise level of desired
fluorescence expression. Plasmid DNA from the selected insulated cassettes are
purified using commercial DNA purification kits (Table 3.3) and then sequenced.
The DNA spacer sequence thus obtained is used to design new promoter parts for
the final target device.
Chapter 4
DNA Spacers: Preliminary Work
4.1 Introduction
I begin this chapter with my initial exploration of component transcription unit order
on the overall expression of a complex device. My test circuit in this experiment and
in all subsequent component order investigations is a 4 transcription unit (TU) TetR
inverter (NOT-gate) inducible by L-arabinose. In order to facilitate the measurement
of the effect of component transcription unit order on device expression, I stripped
my inverter circuit of all cis-regulation, decoupled the expression of AraC from its
native pC promoter and put it under the control of the strong constitutive minimal
promoter J23100. In this design, all 24 permutations of the four transcription units
are valid inverter designs and should – in theory – have an identical expression
profile (See Figure 4.1). My inverter circuit is induced through double inversion: the
repressor AraC is constitutively expressed, which represses promoter pBAD. This
AraC represses the expression of TetR and GFP from both instances of the pBAD
promoter. Arabinose induction is achieved by growing the E. coli containing my
inverter overnight (14 hours) in the presence of 1 mM L-arabinose. GFP and RFP
measurements are taken in only the ON and OFF states of the inverter. Upon
induction, the arabinose sugar binds to AraC and the pBAD promoter is induced
resulting in the production of TetR and GFP proteins. TetR represses promoter
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pTet and RFP expression is inhibited.
Genetic circuits are by convention assembled in the order in which the genetic
logic is executed, probably because such a design is intuitive to understand and
probably also because it is quicker to assemble this way and intuitively easy to follow
such a device. Therefore, if a genetic device does not contain cis-regulation through
DNA looping or similar mechanisms, there are no design constraints that necessitate
that the modular genetic components be arranged in the conventional order. In my
inverter circuit, each transcription unit is a modular component. Therefore, changing
the order of the transcription units should yield devices of equivalent expression.
However, fluctuations in the DNA sequences at the junctions of genetic parts or
larger modular components are known to cause unpredictable changes in circuit
expression [11, 13]. I wanted to assess the severity of such context effects.
I assembled the transcription units (TUs) of a 4 TU inverter (NOT-gate) in the
23 other possible tandem permutations of the four transcription units that my TetR
inverter were composed of. All transcription units were still arranged in tandem
to each other on the same strand of DNA. The assumption that I was testing was
that all 24 permutations of my inverter circuit would nominally display basic inverter
behavior: the expression of the output, RFP, would go down upon induction, and the
expression of GFP, which is an indirect measure of the TetR (L-arabinose is added
to saturation) would increase upon induction.
I assumed the alternate configurations would be equivalent in its expression profile
to the device assembled in the conventional order. The 24 configurations of my single
inverter demonstrated very different expression profiles, and it appeared that I saw
a pattern of high GFP expression when pBAD-GFP was flanked by the scar “A”
(5’-GGAG) immediately upstream of the pBAD promoter (Figure 4.2). In the most
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stark instance, one inverter device showed a 22.5x increase in GFP expression change
on induction compared to the conventional design where the GFP expression did not
change at all. Later in Chapter 6, I show improvement in inverter expression profile
as well as the improvement in the GFP and RFP expression fold changes on induction
(Chapter 6).
Figure 4.1: Bacterial transcriptional inverter (NOT-gate) and experimental design:
(a) The experiments in this study were performed using a bacterial, monocistronic,
transcriptional TetR-inverter composed of 4 tandem Transcriptional Units (TUs)
assembled by the MoClo DNA assembly method. Circles between transcriptional
units represent the 4 bp scars left behind 5’ and 3’ of each TU in the final construct
post-assembly. The inverter is inducible by L-Arabinose. Native arabinose regulation
was decoupled for greater control over device performance. All regulation is in trans.
In the uninduced (OFF) state, AraC represses pBAD resulting in minimal TetR
and GFP expression. In the absence of TetR, RFP is expressed. On induction
(ON) with L-arabinose, TetR and GFP are expressed. TetR represses the promoter
pTet, resulting in inhibition of RFP signal. (b) Keeping the orientation of the TUs
unaltered, the order of TUs within the inverter are shuffled to produce 24 (4 x 3 x 2
x 1) different configurations of the same inverter. All permutations are done at the
level of TU only.
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When I started this work, I did not make any distinction between the order of the
transcriptional units within the tested inverter and the order of 4 bp MoClo assembly
scars at the 5’ boundary of each promoter within my inverter that are left behind
after the cloning process. However, as I progressed through my research, it became
clear that the 4 bp scar at the 5’ boundary of a promoter had a significant impact on
promoter expression. I thus focused my research efforts on eliminating the variations
that were caused by DNA fluctuations at the 5’ junctions of promoters. While in my
work, the DNA bases at the 5’ boundary of a promoter happen to be a cloning scar
that could have been avoided by the use the Gibson DNA assembly method [26] or
or DNA synthesis, composing promoter parts into devices makes variations at the
junctions of promoters unavoidable.
Finding no clear criteria for either DNA spacer length or base composition charac-
teristics in the literature, I chose to begin with randomized DNA sequences ensuring
that the candidate spacer sequences did not form any stable secondary structures
that could possibly occlude transcription, or themselves have any transcription acti-
vating or enhancing properties. By chance the selected spacers fell within the normal
base composition of the neutral DNA sequences found between E. coli operons that
do not contain any known active gene regulatory elements [48]. I do not make any
claims on testing a statistically significant number of DNA spacers in my preliminary
work. Following up on the partial success of my preliminary work, I first expanded
my DNA spacer set to avoid having to reuse a spacer twice within a single genetic
device (See Figure 4.11). I recreated my 24 inverter permutations with promoters
insulated with rationally designed DNA spacers, but found them to be unreliable
(See Figure 4.12).
These failures led me to believe that designing DNA spacers rationally may not
45
be possible. This led to the development of the DNA spacer generation and high-
throughput screening protocol. Using this technique I screened samples from libraries
of insulated promoter circuits using the promoters from my test inverter (J23100,
pBAD, pTet). These results are presented in Figures 5.2, 5.7 and 5.8 in Chapter 5.
4.2 Problem Statement: Synthetic genetic device perfor-
mance is dependent on the order of intermediate tran-
scription units
I assembled all 24 permutations possible from the reorganization of the transcription
units of my 4 transcription unit inverter described in Figure 4.1 above using the
MoClo DNA assembly method. The inverters were grown overnight in LB Broth
as described in Chapter 3 and then grown for a second night in the presence (ON
state) or absence (OFF state) or 1 mM L-arabinose. The inverters were diluted in
1x Phosphate Buffered Saline (PBS) as described in Chapter 3, Section 3.3.2 and
the expression of green and red fluorescence was measured by flow cytometry. All
samples were tested in triplicate. Fluorescence measurements were converted to
absolute units (MEFLs) using the TASBE Tools [7, 9].
I assessed the effect of changes in the local DNA sequence context of component
modules on overall device performance. Local DNA context of component TUs is
represented by the 4 bp MoClo assembly scar flanking the 5’ boundary of each TU
promoter. The 24 theoretically equivalent inverters varied greatly from configuration
to configuration in their overall performance profiles. 8 out of 24 devices show almost
no change in either their GFP and RFP expression levels upon induction. While
GFP expression levels either change little or increase in all devices, in 8 of the
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24 devices, the output (RFP) expression levels increase rather than decrease upon
arabinose-induced TetR repression of the pTet promoter driving RFP expression.
Furthermore, we observed a clear pattern of high GFP expression, but varying levels
of RFP repression in all devices where the pBAD-GFP TU was flanked on the 5’ end
by the MoClo assembly scar “A” (pBAD-GFP A).
4.3 Promoter Architecture for uninsulated promoters J23100,
pBAD and pTet
The constitutive promoter J23100, the inducible promoter pBAD, and the repressible
promoter pTet, used to design the 24 equivalent inverters (Figure 4.1 and Figure
4.2) were Modular Cloning (MoClo)-format versions of the J23100, pBAD and pTet
promoters from the Registry of Standard Biological Parts [35]. No DNA sequence
from the original promoter parts were deleted or rearranged in constructing the
inverter circuits used in this study.
The promoter architecture for promoters J23100, pBAD and pTet without the 5’
and 3’ MoClo fusion sites (scars) are shown below in Figure 4.2, Figure 4.3 and, Fig-
ure 4.5, respectively. For each promoter, the first nucleotide marks the 5’ boundary
of the promoter and the last nucleotide marks the 3’ boundary of the promoter. The
5’ and 3’ MoClo fusion sites begin at the 5’ and 3’ boundaries of each promoter.
4.3.1 Uninsulated J23100 promoter architecture
The constitutive promoter J23100 is a strong, minimal synthetic promoter that is part
of a family of synthetic minimal constitutive promoters created by combinatorially
varying the consensus sequences of a synthetic constitutive promoter created by
combining the canonical RNA polymerase (RNAP) sigma subunit binding consensus
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sequence centered at -35 and -10 relative to the transcription start site separated by a
17 base pair spacer. Promoter J23100 is a strong promoter because its expression level
is closest to wild-type expression: its -35 sequence (5’-TTGACG-3’) varies from the
canonical consensus sequence (5’-TTGACA-3’) by just one base and its -10 sequence
(5’-TACAGT-3’) varies from the canonical consensus sequence (5’-TATAAT-3’) by
two bases (see Figure 4.6).
4.3.2 Uninsulated pBAD promoter architecture
The inducible promoter pBAD used in this study is the MoClo version of the pro-
moter I13453 from the Registry of Standard Biological Parts [35]. The synthetic
promoter pBAD (see Figure 4.3) is 130 base pairs long and contains operator se-
quences AraI1 and AraI2 but not operator AraO2, in addition to the -35 and -10
RNAP sigma subunit binding sites.
In the wild-type pBAD promoter, a dimer of AraC binds to the operators I1 and
O2 in the repressing state, resulting in looping of the promoter over itself. Upon
addition of the inducer, L-arabinose, AraC undergoes a conformational change mak-
ing long-distance looping impossible and thus restricting AraC to binding proximal
operator sites araI1 and araI2. The disappearance of the DNA loop and the occu-
pation of the I2 site lead to pBAD activation [52]. Figure 4.4 shows the mechanism
of promoter pBAD repression and activation by the repressor, AraC, in the absence
and presence of Arabinose, respectively.
The synthetic promoter (see Figure 4.3) is shorter (130 base pairs (synthetic) vs
284 base pairs(wild-type)) and is missing the wild-type operator araO2 site that binds
the C-terminus of one molecule of the AraC repressor dimer in the uninduced (-Ara)
state. The synthetic promoter does not loop around in the uninduced state. The C-
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terminus of one AraC monomer remains unbound in the synthetic pBAD promoter,
which may possibly explain its leaky expression compared to the wild-type pBAD
promoter.
Interestingly, the pBAD promoter is neither <100 base pairs in length, nor is
there a protein binding site immediately downstream of the promoter 5’ boundary.
Yet, promoter pBAD is affected significantly by one (Scar “F”, 5’-CGCT-3’) of the
four scars introduced upstream of its 5’ boundary as a result of DNA assembly using
the MoClo DNA assembly method (See Figure 4.7). It is possible that the scar “F”
introduces long-range/off-target effects that are affecting promoter expression.
4.3.3 Uninsulated pTet promoter architecture
Promoter pTet (Figure 4.5) is a 54 base pair, regulatable promoter that binds, in
addition to RNA polymerase enzyme, its cognate helix-turn-helix (HTH) repressor,
TetR. Promoter pTet is constitutively expressed unless its repressor protein TetR is
bound to the TetR-O1 and TetR-O2 sites. The pTet promoter used in the assembly of
the inverters in this study is the MoClo-format version of the R0040 pTet promoter
part from the Registry of Standard Biological Parts [35]. In the absence of the
repressor, TetR, RNAP binds the -35 and -10 sequences. When TetR in present,
it occupies the TetR-O1 and TetR-O2 sites, blocking RNAP access to the -35 and
-10 sequences. No base pairs were deleted from the original Registry promoter part.
The 5’ MoClo scar gets added immediately upstream of the 5’ boundary of the pTet
promoter part. The TetR-O1 ends at the 5’ boundary of the promoter and is not
buffered by any additional DNA sequence.
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4.4 Characterization of promoter expression in isolation
4.4.1 Inverter component TU promoters are affected by 4 bp MoClo
fusion sites immediately upstream of promoter
It has recently been reported that minimal constitutive promoters are affected by
local DNA sequence context of as few as 4 bp of DNA immediately 5’ of the promoter
[38]. However, the study only investigated two MoClo fusion sites, fusion site “A”
(5’- GGAG) compared to fusion site “E” (5’- GCTT); our 4-TU inverters contained
in addition to fusion sites “A” and “E”, fusion sites “F” (5’- CGCT) and “G” (5’-
TGCC) upstream of promoter elements. Furthermore, the study did not investigate
the effect of upstream DNA sequence on the expression of regulatable promoters like
the inducible pBAD and the repressible pTet promoters used to build the 24 inverter
sets. To assess whether the upstream 4 bp MoClo fusion sites could be responsible
for the observed order dependent expression of the devices in the 24 inverter set, I
tested each promoter-fusion site combination from my test inverter in isolation.
4.4.1.1 J23100 E and J23100 F expression is >10.5x lower than J23-
100 A expression
To test the effect of 4 bp MoClo fusion site 5’ of promoter J23100, I built four indi-
vidual GFP expression cassettes with the four 4 bp fusion sites, “A”, “E”, “F” and
“G” upstream of promoter J23100 and measured their expression by flow cytome-
try. Circuits were grown overnight in LB Broth as described in Chapter 3. Circuits
were diluted in 1x Phosphate Buffered Saline (PBS) as described in Chapter 3, Sec-
tion 3.3.2 and the expression of green fluorescence measured. All samples were tested
in triplicate. Fluorescence measurements were converted to absolute units (MEFLs)
using the TASBE Tools [7, 9]. J23100 A (8.27 x 104 MEFLs) and J23100 G (7.95 x
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104 MEFLs) expression varied minimally. However, J23100 E (6.63 x 103 MEFLs)
and J23100 F (7.54 x 103 MEFLs) expression were observed to be 12.5x and 11.0x
lower than J23100 A respectively.
The expression of the J23100-AraC X (where X is either fusion site “A”, “E”, “F”
or “G”) TU determines the amount of AraC protein in our inverters, which binds
with the inducer L-arabinose to induce the expression of TetR to repress output
RFP expression when the inverter circuit is induced. Lesser AraC between devices
(dictated by the upstream fusion site based on the position of the J23100-AraC
TU in the ivnerter) will likely impact inverter performance. It may be possible to
regularize AraC levels between different inverter configurations in the 24 inverter set
by insulating the J23100 promoter against its upstream DNA sequence context.
4.4.1.2 pBAD F expression is 6.50x lower than pBAD A expression
Regulatable promoters are considered less likely to be affected by fluctuations in
the DNA sequence immediately upstream of the promoter [62, 22]. However, to our
knowledge, this has not been investigated.
To test the effect of the DNA sequence context of a 4 bp MoClo fusion site 5’ of
inducible promoter pBAD, we built 4 individual GFP expression cassettes with the
four 4 bp fusion sites, “A”, “E”, “F” and “G” upstream of promoter pBAD and mea-
sured their expression by flow cytometry (see Figure 4.7). Circuits were first grown
in LB broth with appropriate antibiotics as described in Chapter 3, Section 3.3.
Circuits were then diluted in 1x Phosphate Buffered Saline (PBS) as described in
Chapter 3, Section 3.3.2 and the expression of green fluorescence measured. All sam-
ples were tested in triplicate. Fluorescence measurements were converted to absolute
units (MEFLs) using the TASBE Tools [7, 9]. pBAD G (6.76 x 103 MEFLs; 1.44x
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higher than pBAD A expression) had the highest expression, followed by pBAD A
(3.71 x 103 MEFLs) and pBAD E (2.69 x 103 MEFLs, lower than pBAD A by 1.38x).
However, pBAD F expression (5.75 x 102 MEFLs, 6.46x lower than pBAD A) was
significantly lower than pBAD A and could be partly responsible for the observed
order dependence of the 24 inverter set.
4.4.1.3 pTet promoter expression is unaffected by its upstream MoClo
fusion site
To test the effect of the DNA sequence context of a 4 bp MoClo fusion site 5’ of the
repressible promoter pTet, we built 4 individual RFP expression cassettes with the
four 4 bp fusion sites, “A”, “E”, “F” and “G” upstream of pTet and measured their
expression by flow cytometry (see Figure 4.8). Circuits were diluted in 1x Phosphate
Buffered Saline (PBS) as described in Chapter 3, Section 3.3.2 and the expression
of green fluorescence measured. All samples were tested in triplicate. Fluorescence
measurements were converted to absolute units (MEFLs) using the TASBE Tools
[7, 9].
Unlike the constitutive minimal promoter, J23100, and the inducible promoter
pBAD, the pTet promoter was found to be robust and expression from it is not
affected by the base composition of the 4 bp MoClo fusion site immediately upstream
of the promoter in isolation. Insulating pTet in the 24 inverter sets appeared to not
be essential to eliminating upstream promoter sequence-based order dependence.
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4.4.2 Neutral DNA sequences do not reliably insulate promoters from
upstream local DNA sequence context
In order to determine the shortest length of DNA spacer sufficient for insulating pro-
moters from fluctuating upstream DNA sequence, two each of 12nt, 24nt and 36nt
randomized DNA spacers were inserted upstream of constitutive promoters J23100,
J23101 and J23104 as well as repressible promoter pTet (see Figure 4.9). Tested
DNA spacer sequences were screened for promoter activity or for stable secondary
structures that could potentially occlude access to the promoter and candidate spacer
sequences with either were eliminated. The base composition of each pair of 12nt,
24nt and 36nt DNA spacer candidates were similar in their CG%. Insulated pro-
moters were cloned into RFP expression cassettes with a medium-strong bicistronic
design (BCD) RBS element BCD12 using MoClo DNA assembly. All expression
cassettes were designed with MoClo fusion site “E” (5’-GCTT) upstream of the pro-
moter. Circuits were diluted in 1x Phosphate Buffered Saline (PBS) as described in
Chapter 3, Section 3.3.2 and the expression of red fluorescence measured. All sam-
ples were tested in triplicate. Fluorescence measurements were converted to absolute
units (MEFLs) using the TASBE Tools [7, 9].
We found that for all promoters tested, the mean RFP expression of the two
tested 12nt and 24nt spacers values did not fall within two standard deviations of
each other (see Figure 4.9). However, the mean RFP expression values for the two
tested 36nt spacers upstream of constitutive promoter J23100 (J23100-36INS-1 mean:
2.71 x 103 MEFLS; range: 2.65 x 103 - 2.77 x 103 MEFLS, and 36INS-2 mean: 2.75 x
103 MEFLS, range: 3.00 x 3 - 2.52 x 103) and repressible promoter pTet (pTet-36INS-
1 mean: 1.12 x 103 MEFLS; range: 2.84 x 103 - 444. MEFLS, and pTet-36INS-2
mean: 1.08 x 103 - 886.) fell within two standard deviations of each other and the two
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spacers could be considered equivalent. However, for constitutive promoter J23101
and J23104 the mean RFP expression for the two spacers tested were not within two
standard deviations of each other.
4.4.3 Rationally designed “neutral” 36nt DNA spacer sequences affect
promoter expression
The effect of the tested 36nt DNA spacer sequences when used to insulate against
the 5’ MoClo fusion site was tested (see Figure 4.11). Insulated versions of J23100 A
and J23100 E RFP expression cassettes was assembled using MoClo and compared
to each other and to the uninsulated J23100 A or J23100 E, respectively. To test,
circuits were first grown in LB broth with appropriate antibiotics as described in
Chapter 3, Section 3.3. Circuits were then diluted in 1x Phosphate Buffered Saline
(PBS) as described in Chapter 3, Section 3.3.2 and the expression of red fluorescence
measured. All samples were tested in triplicate. Fluorescence measurements were
converted to absolute units (MEFLs) using the TASBE Tools [7, 9].
Insulating J23100 A and J23100 E with the two tested rationally designed 36nt
DNA spacers reduced the expression difference between upstream MoClo fusion site
“A” (5’-GGAG) and “E” (5’-GCTT) from 3.5x to 1.34x (INS-1) and 1.19x (INS-
2) respectively. The mean RFP expression between J23100 A and J23100 E for
both tested DNA spacers was found to be within 2 standard deviations of each
other and therefore not statistically significant. For each rationally designed DNA
spacer tested, however, insertion of the spacer sequence upstream of promoter J23100
depressed RFP expression by 10.24x for J23100 A insulated with INS-1 and 9.93x for
J23100 E insulated with INS-2 compared to the uninsulated version of the promoter.
Mean RFP expression for J23100 E insulated with INS-1 and INS-2 were lower than
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the uninsulated J23100 E by 3.91x and 3.37x, respectively.
4.4.4 Expanding the rationally designed J23100 A 36nt DNA spacer li-
brary did not yield DNA spacers providing consistent insulation
It was possible that that the lower expression of the 36nt DNA spacers tested above
compared to the uninsulated J23100 promoter was due to random chance. To check
if this was true, the 36nt DNA spacer library was expanded from 2 DNA spacers
to 10 spacers. The selection criteria for spacer sequences was kept identical to that
described above in Section 4.4.2. Spacers were inserted 5’ of promoter J23100 sepa-
rating the promoter from its upstream MoClo fusion site. RFP expression cassettes
were created using the expanded insulated J23100 A library using BCD12 as above
using MoClo DNA assembly. To test, circuits were first grown in LB broth with
appropriate antibiotics as described in Chapter 3, Section 3.3. Circuits were then di-
luted in 1x Phosphate Buffered Saline (PBS) as described in Chapter 3, Section 3.3.2
and the expression of red fluorescence measured. All samples were tested in tripli-
cate. Fluorescence measurements were converted to absolute units (MEFLs) using
the TASBE Tools [7, 9].
Mean fluorescence expression values were compared to RFP expression of the
uninsulated J23100 A promoter. With the exception of one DNA spacer (INS-10),
which failed to clone, RFP expression cassettes were generated for all other DNA
spacers (spacer sequences available in Table 3.8). All insulated J23100 A constructs
showed depressed RFP expression compared to uninsulated J23100 A. Furthermore,
INS4, INS-6, INS-8 and INS-9 cassettes demonstrated lower RFP expression com-
pared to other insulated J23100 A cassettes while INS-5 and INS-7 showed high RFP
expression compared to J23100 A cassettes insulated with INS-1, INS-2 and INS-3.
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4.4.5 Rationally designed DNA spacers provide unreliable insulation
The inverters that were closest to each other in performance were selected to insu-
late promoters in the 24 permutations set of the test inverter. I selected 4 DNA
spacers as the two instances of pBAD promoter in each inverter were to be insulated
with separate yet equivalent DNA spacers to minimize artifacts from homologous
recombination. Although pTet was found to be robust, we chose to insulate it for
consistency throughout the device. The DNA spacers were selected from the tested
insulators in Figure 4.11. The sequences for the insulated promoters can be found
in Table 3.8.
Table 4.1: Composition characteristics for rationally designed DNA spacer
sequences. Selected sequences were all 36 bp, had a CG% content of between 40%
and 60%, formed no stable secondary structures and did not contain any known
promoter activity.
Name Sequence TmC CG% nt Promoter
INS-1
cctgcagtattcattttcagc
ttacggaaggtagat
74.2 41.7 36 J23100
INS-2
cgttgttcgcgaccctgttc
tgaggcaatgttgggc
86.9 58.3 36 pBAD
INS-3
tagcacgcttttctgcgtatg
gttggtcagcttcta
79.1 47.2 36 pBAD
INS-5
cggagagaatacatagtaaa
gaaacctcactgttgt
70.8 38.9 36 pTet
Using these insulated promoter parts, we rebuilt and tested our 24 inverter per-
mutation set using MoClo assembly. The inverters were grown overnight in LB Broth
as described in Chapter 3 and then grown for a second night in the presence (ON
state) or absence (OFF state) or 1 mM L-arabinose. The inverters were diluted in
1x Phosphate Buffered Saline (PBS) as described in Chapter 3, Section 3.3.2 and the
expression of green and red fluorescence was measured by flow cytometry. All sam-
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ples were tested in triplicate. Fluorescence measurements were converted to absolute
units (MEFLs) using the TASBE Tools [7, 9].
We found that while insulating the promoters in our 24 inverter set did eliminate
the pattern of high GFP expression in inverter devices where the pBAD-GFP TU
was flanked by the assembly scar “A” (pBAD-GFP A), it did not regularize the
expression profile of the devices or relieve the variations between inverters.
4.5 Conclusions
I show here that genetic inverters equivalent in design behave unpredictably resulting
in faulty device behavior (See Figure 4.2). I have also shown that this performance
unpredictability is dependent on the order of transcription units within the device.
In a comparison of the GFP and RFP fold change profiles of 24 equivalent invert-
ers, I found that inverter devices in which the pBAD-GFP was the first transcription
units transcription unit showed noticeably higher GFP expression compared to when
pBAD-GFP was the second, third or fourth transcription unit in the device. Pro-
moter parts appear to be sensitive to changes in DNA sequence at their 5’ boundaries.
Most commonly used BioBrick [35] promoter parts were originally designed with-
out any buffering sequences between key protein binding sequences like the -35 RNA
Polymerase (RNAP) binding sites in minimal constitutive promoters or the tran-
scription factor binding sites for regulated promoters and have been used as such in
the creation of engineered genetic devices. When these promoter parts are incorpo-
rated into new combinations and into new plasmid vector backbones, the sequence at
the 5’ junctions of the promoters is altered. In the absence of buffering sequences at
the 5’ promoter boundaries, these altered 5’promoter junctions could impact protein
binding and thus result in a different level of expression than in the original context in
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which the promoter was characterized. An investigation into the mechanism of such
variations in promoter activity as a result of altered genetic context is beyond the
scope of this study, but would certainly provide valuable information for improved
synthetic promoter part design for new synthetic biology parts.
Neutral DNA sequences (spacers or insulators) have previously been used to buffer
promoter parts from upstream DNA sequences with transcription activating prop-
erties in bacteria [16]. However, these upstream transcription activating sequences
are traditionally -60 to -40 base pairs upstream of the transcription start site (TSS).
DNA spacers have not been used previously as a tool to insulate against sequence
variations immediately upstream a defined promoter part. As such, there were no
available parameters for successful spacer design. I defined a “neutral” DNA sequence
as one that matched the base composition of intergenic regions in E. coli between
operons [48]. Through my preliminary work on DNA spacer selection, I concluded
that 36 bp DNA spacers were often sufficient for insulating promoters from expression
variations caused by changes in the DNA sequence at the 5’ promoter boundary.
My preliminary work on the selection of DNA spacers made it clear that designing,
testing and selecting DNA spacers would prove a laborious process. Although a
very small number of DNA spacers were tested, the DNA base composition for the
spacers with the most similar expression profiles did not fall within a narrow range by
which to establish any selection criteria. Without a more nuanced understanding of
sequences that would provide reliable and adequate insulation, designing and testing
spacers individually appeared to be a laborious and fruitless process. At this point,
I abandoned this approach for a newer methodology that is described in Chapter 3,
Section 3.2.3.1 and shown in Figure 3.2.
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Expression profile of the 24 uninsulated inverter permutations of our test
TetR inverter upon induction with L-arabinose. (Continued from previous
page.) Assembly scars upstream of promoters cause anomalous expression and or-
der dependence of modules in genetic devices assembled using Golden Gate-derived
DNA assembly methods. Comparison of GFP and RFP fluorescence fold changes
upon induction with L-arabinose of the 24 inverter permutation set in which no
promoters are insulated reveals device-to-device variations and a clear pattern of
high GFP fluorescence in inverters where pBAD-GFP A was TU1 in the inverter
configuration. All fluorescence readouts were converted to absolute units (MEFLs).
Conversion of fluorescence readouts to MEFLs was done using the TASBE tools by
our collaborators.
Figure 4.2: J23100 promoter architecture. Promoter J23100 is a 35 base pair
minimal constitutive promoter consisting of -35 and -10 RNA polymerase binding
sites separated by 17 base pairs. The J23100 promoter does not contain any DNA
sequences that buffer the -35 RNA polymerase sigma binding site from fluctuating
DNA sequences upstream of its 5’ boundary. Promoter J23100 sequence is shown in
yellow. -35 and -10 RNAP binding site sequences are shown in orange.
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Figure 4.3: pBAD promoter architecture. Promoter pBAD is a 130 base pair
inducible promoter consisting of two operator sequences that bind the repressor,
AraC, in addition to the -35 and -10 RNA polymerase sigma subunit binding sites.
The pBAD promoter contains 39 base pairs between the 5 boundary of the promoter
and the first protein binding site. Promoter pBAD sequence is shown in light blue. -
35 and -10 RNAP binding site sequences are shown in orange, and the AraC operator
sites are shown in yellow.
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Figure 4.4: Model of AraC induction by L-arabinose. A dimer of AraC binds
to the operators I1 and O2 in the repressing state (N and C denote the N and C-
terminal domains of AraC, respectively). Upon addition of the inducer L-arabinose
(represented by filled circles), AraC undergoes a conformational change that makes
long-distance looping impossible and so restricts binding to the proximal target sites
I1 and I2 . The disappearance of the DNA loop and the occupation of the I2 site lead
to activation at PBAD . The depicted sizes and distances are not drawn to scale. An
asterisk (*) indicates the intervening base-pairs between araI1 and araO2. Figure
and figure legend reproduced from How AraC Interacts Specifically with its Target
DNAs, by P. Niland et al., Journal of Molecular Biology, 1996. [52]
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Figure 4.5: pTet promoter architecture. Promoter pTet is a 54 base pair repress-
ible promoter consisting of two operator sequences (TetR-O1 and TetR-O2) that bind
the repressor, TetR, in addition to the -35 and -10 RNA polymerase sigma subunit
binding sites. The pTet promoter does not contain any DNA sequences that buffer
the TetR-O1 from fluctuating DNA sequences upstream of its 5’ boundary. Promoter
pTet sequence is shown in light blue. TetR-O1 and TetR-O2 sites are shown in yellow
and the -35 and -10 RNAP binding site sequences are shown in orange.
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Figure 4.6: Constitutive promoter J23100 expression affected by upstream
DNA sequence. Individual J23100-GFP expression cassettes were built using
J23100 A, J23100 E, J23100 F and J23100 G using the RBS B0032m BC and double
terminator B0015 with the appropriate 3’ fusion sites as listed in Table 3.5. GFP
fluorescence was used to measure promoter expression. J23100 A and J23100 G
had similar expression levels, while both J23100 E and J23100 F expression were
>10x lower than J23100 A expression. Altering 4 bp 5’ of promoter J23100 GGAG
(J23100 A) to GCTT (J23100 E) or CGCT (J23100 F) lowered expression GFP ex-
pression from promoter by 12.5x and 11x respectively. GFP expression was not
significantly altered when upstream fusion site was modified to TGCC (J23100 G).
All fluorescence measurements are in MEFLs.
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Figure 4.7: Inducible promoter pBAD expression affected by upstream
DNA sequence. Individual pBAD-GFP expression cassettes were built using
pBAD A, pBAD E, pBAD F and pBAD G using the RBS B0034m BC and dou-
ble terminator B0015 with the appropriate 3’ fusion sites as listed in Table 3.5.
GFP fluorescence was used to measure promoter expression. pBAD A, pBAD E and
pBAD G expression levels were within 2-folds of each other. pBAD F expression
was 6.50x lower than pBAD A expression. Altering 4 bp 5’ of promoter pBAD from
GGAG (pBAD A) to CGCT (pBAD G) increased GFP expression from promoter
by 1.44x. All fluorescence measurements are in MEFLs.
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Figure 4.8: Repressible promoter pTet expression is unaffected by changes
in its upstream DNA sequence Individual pTet-RFP expression cassettes were
built using pTet A, pTet E, pTet F and pTet G using the RBS B0030m BC,
E1010 CD and double terminator B0015 with the appropriate 3’ fusion sites as listed
in Table 3.5. RFP fluorescence was used to measure promoter expression. The ex-
pression from the four MoClo fusion site variants of pTet-RFP were statistically
indistinguishable from each other. All fluorescence measurements are in MEFLs.
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Figure 4.9: RFP expression from promoter cassettes insulated with 12nt,
24nt and 36nt DNA spacer sequences Three DNA spacer lengths were tested to
determine minimum spacing required for promoter insulation. Two spacers of each
length were tested to reduce the chances of homologous recombination if multiple in-
sulated promoters need to be incorporated into a single target device. Equivalence of
DNA spacers was measured by comparing mean RFP expression of the two insulated
versions of each promoter. All measurements are in MEFLs. (a) The two sampled
12nt spacers do not reliably insulate any tested promoter. (b) The two sampled 24nt
spacers do not reliably insulate any tested promoter. (c) The two tested 36nt spacers
reliably insulate constitutive promoter J23100 and repressible promoter pTet but not
constitutive promoters J23101 or J23104.
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Figure 4.10: Insulated promoters reduce dependence on upstream DNA
sequence context at the cost of altered promoter expression levels J23100 A
or J23100 E were insulated with the two previously tested rationally designed 36nt
DNA spacers. Insulated promoters were assembled into RFP expression cassettes
with bicistronic design (BCD) RBS element BCD12. Insulated J23100 promoters
show 10x lower expression than the uninsulated promoter. Insulating promoters with
36nt DNA spacers reduce the upstream DNA sequence-dependent expression changes
but do not eliminate them entirely. Insulated promoter J2310. All measurements
are in MEFLs.
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Figure 4.11: Expanding the rationally designed 36nt DNA spacer library
showed variability in insulated J23100 A expression J23100 A was insulated
with DNA spacers INS1-INS10. Insulated promoters were assembled into RFP ex-
pression cassettes with bicistronic design (BCD) RBS element BCD12. The expanded
insulated J23100 promoter library continues to show approximately 10x lower ex-
pression than the uninsulated J23100 A promoter. Insulated promoter J2310 All
measurements are in MEFLs.
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Expression profile of 24 inverter set with all promoters insulated with
rationally selected DNA spacers upon induction with 1mM L-arabinose.
(Continued from previous page.) Rationally designed DNA spacers do not guarantee
reliable insulation. Comparison of GFP and RFP fluorescence fold changes upon
L-arabinose induction of 24 inverter permutations built with rationally designed in-
sulated promoters removes previously observed high GFP fold change pattern from
the uninsulated inverter set, but does not eliminate device to device expression fluc-
tuations. All fluorescence readouts were converted to absolute units (MEFLs).
Chapter 5
DNA Spacers: High-throughput screening
of insulated promoter libraries
5.1 Introduction
In this chapter I present my results from my novel DNA spacer screening method.
I screened almost 2000 samples from insulated J23100 A, J23100 E, J23100 H and
J23100 K libraries (a fusion site that is not part of my inverter designs) to compare
patterns of distribution of insulated expression cassettes. I further apply my spacer
screening methodology to the other promoters in my test inverter, pBAD and pTet.
As promoters pBAD and pTet are regulatable and have transcription factor binding
sites that a good DNA spacer candidate should not disrupt, I chose to evaluate them
in a way such that I could verify that the DNA spacer I selected from my library did
not have any impact on transcription factor binding. In fact, the insulated library
for promoter pTet was generated within the context of one of the permutations
of the test inverter. The detailed methodology is described in Section 3.2.3.1 and
a schematic representation is shown in Figure 3.2. Briefly, a library of insulated
promoter expression cassettes upstream of any chosen promoter could be generated
by performing an inverse PCR reaction using 100% degenerate primers followed by
a blunt-end ligation to circularize the linear PCR products. The library is then
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transformed into E. coli (Section 3.2.5 and screened by flow cytometry against a
reference device to obtain DNA spacers that provide the precise level of insulation
needed.
5.2 Results
5.2.1 Distribution of 36nt-insulated J23100 expression cassettes
Using our new DNA spacer library generation and screening method described in
Section 3.2.3.1, we created and screened approximately 2000 total samples from 36nt-
J23100 A, 36nt-J23100 E and 36nt-J23100 H (fusion site not in 5’ of 24 inverter set
designs; 5’- ACTA) and 36nt-J23100 K (fusion site not in 5’ of 24 inverter set designs;
5’- AGTC) sequences to sample the range of expression level distribution for 36nt
DNA spacer sequences placed upstream of promoter J23100, and also to screen for
a DNA spacer to use upstream of promoter J23100 in the 24 inverter set designs.
Insulated J23100 expression cassette libraries were generated as described in
Chapter 3, Section 3.2.3.1 and shown in Figure 3.2. Each colony from a library
transformation plate represents a distinct insulated promoter cassette. Circuits were
first grown in LB broth with appropriate antibiotics as described in Chapter 3,
Section 3.3. Circuits were then diluted in 1x Phosphate Buffered Saline (PBS) as de-
scribed in Chapter 3, Section 3.3.2 and the expression of green fluorescence measured.
As this was a screen, samples were not in triplicate. Fluorescence measurements were
converted to absolute units (MEFLs) using the TASBE Tools [7, 9]. My collabora-
tors assisted me with plotting the expression distribution for the insulated promoter
libraries.
We observed a very wide range of expression levels as can be seen in Figures
5.1, 5.2, 5.3 and 5.4, respectively. Addition of some spacers greatly reduced GFP
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expression while others increased it.
5.2.1.1 Distribution of GFP expression of screened samples from 36nt-
J23100 A-GFP DNA spacer library
Figure 5.1: Distribution of insulated 36nt-J23100 A GFP library. Expression
of approximately 1200 samples from the 36nt-J23100 A spacer library were checked
by flow cytometry for GFP expression levels. The orange bar marks the expression
level of insulated J23100 A cassettes with the same expression level as the uninsulated
J23100 A-GFP reference circuit. The expression distribution contained a clear peak.
All fluorescence readouts were converted to absolute units (MEFLs).
Figure 5.1 shows the distribution of approximately 1200 36nt insulated J23100 A-
GFP cassettes. The expression of the reference control (uninsulated J23100 A-GFP;
2.45 x 104 MEFLs) fell within the body of the bulk of the distribution but was lower
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than peak insulated cassette expression. Most spacers were found to exert a strong
genetic context effect on the J23100 promoter. In approximately 100 of the tested
insulated J23100 A samples, the addition of a spacer abolished expression to almost
negative control autofluorescence levels.
5.2.1.2 Distribution of GFP expression of screened samples from 36nt-
J23100 E-GFP DNA spacer library
Figure 5.2: Distribution of insulated 36nt-J23100 E GFP library. Expression
of approximately 400 samples from the 36nt-J23100 E spacer library were checked
by flow cytometry for GFP expression levels. The orange bar marks the expression
level of insulated J23100 E cassettes with the same expression level as the uninsulated
J23100 A-GFP reference circuit. The expression distribution had a clear peak. All
fluorescence readouts were converted to absolute units (MEFLs).
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Figures 5.2, 5.3 and 5.4 show the distribution of approximately 400 36nt insu-
lated J23100 X-GFP cassettes in 3 cases. The expression of the reference control
(uninsulated J23100 A-GFP; 2.45 x 104 MEFLs) fell within the body of the bulk of
the distribution but was lower than peak insulated cassette expression. Most spac-
ers were found to exert a strong genetic context effect on the J23100 promoter. In
approximately 10 of the tested insulated J23100 E samples, the addition of a spacer
abolished expression to almost negative control autofluorescence levels.
5.2.1.3 Distribution of GFP expression of screened samples from 36nt-
J23100 H-GFP DNA spacer library
Figure 5.3 shows the distribution of approximately 200 36nt insulated J23100 H-GFP
cassettes. While the expression distribution contained a clear peak, the GFP expres-
sion level of the reference control (uninsulated J23100 A-GFP; 2.45 x 104 MEFLs)
fell within the body of the bulk of the distribution but was lower than peak insu-
lated cassette expression. Most spacers were found to exert a strong genetic context
effect on the J23100 promoter. In approximately 10 of the tested insulated J23100 H
samples, the addition of a spacer abolished expression to almost negative control
autofluorescence levels.
5.2.1.4 Distribution of GFP expression of screened samples from 36nt-
J23100 K-GFP DNA spacer library
Figure 5.4 shows the distribution of approximately 200 36nt insulated J23100 K-GFP
cassettes. The expression of the reference control (uninsulated J23100 A-GFP; 2.45
x 104 MEFLs) fell at the lower end of the distribution of expressions and was lower
than peak insulated cassette expression. Most spacers were found to exert a strong
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Figure 5.3: Distribution of insulated 36nt-J23100 H GFP library. Expression
of approximately 400 samples from the 36nt-J23100 H spacer library were checked
by flow cytometry for GFP expression levels. The orange bar marks the expression
level of insulated J23100 H cassettes with the same expression level as the uninsulated
J23100 A-GFP reference circuit. The expression distribution contained a clear peak.
All fluorescence readouts were converted to absolute units (MEFLs).
genetic context effect on the J23100 promoter. In approximately 10 of the tested
insulated J23100 K samples, the addition of a spacer abolished expression to almost
negative control autofluorescence levels.
5.2.2 Analysis of DNA spacer sequences from J23100 X screens
Approximately 600 insulated cassettes were sequenced in an attempt to investigate
the characteristics of the spacers in the distribution. Of the 600 spacers sequenced,
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we found 2 duplicates from 36nt-J23100 A and 36nt-J23100 E plates (see Figures 5.5
and 5.6). The spacer libraries from which the samples were screened were created
and tested on separate days, so the result is unlikely to be due to contamination.
The CG% of all sequenced spacers ranged from 27.8% to 66.7%. All screened spacer
sequences that were not exactly 36nt in length, or in which promoter or upstream
MoClo fusion site was either missing or mutated were eliminated. Our collaborators
assisted me in presenting this result for visualization.
After trimming, 150 spacer sequences remained from the 600 sequenced samples.
The CG% was recalculated for the trimmed set, but both the mean and median CG%
remained unchanged. The modal expression level of the distribution remained un-
changed. Furthermore, the mean and median CG% of sequenced spacers were 42.7%
and 41.7%, respectively. The modal CG% for these was also 41.7%. A search for
consensus bases or motifs within the trimmed set using the WebLogo 2.8.2 online tool
[65] revealed no consensus patterns. However, we did find that among the trimmed
set of DNA spacers, the final base in the 36nt spacer sequences was predominantly
(deoxy)thymine (T). As such, the screened spacers did not differ significantly from
the rationally designed DNA spacer sequences in Table 4.1.
5.2.3 Distribution of PCR-generated 36nt-insulated pBAD library
The insulated pBAD expression cassette library was generated as described in Chap-
ter 3, Section 3.2.3.1 and shown in Figure 3.2. Each colony from a library transfor-
mation plate represents a distinct insulated promoter cassette. Circuits were first
grown in LB broth with appropriate antibiotics as described in Chapter 3, Section 3.3.
Circuits were then diluted in 1x Phosphate Buffered Saline (PBS) as described in
Chapter 3, Section 3.3.2 and the expression of green fluorescence measured. As
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this was a screen, samples were not in triplicate. Fluorescence measurements were
converted to absolute units (MEFLs) using the TASBE Tools [7, 9]. My collabora-
tors assisted me with plotting the expression distribution for the insulated promoter
libraries.
Using the new PCR-based DNA spacer library generation method utilizing de-
generate primers described in Section 3.2.3.1, a library of 36nt-insulated pBAD F
promoter variants were generated in E. coli. MoClo fusion site “F” (5’-CGCT) was
chosen as the upstream DNA sequence because it caused the largest reduction in
pBAD expression out of the four tested MoClo fusion sites. In order to avoid DNA
spacers that disrupted transcription factor (AraC) binding to the pBAD promoter, a
reference and PCR template genetic circuit was selected that would allow measure-
ment of pBAD-GFP expression before and after induction. Insulated pBAD samples
that failed to show any GFP induction were discarded from consideration. Distribu-
tion of the insulated pBAD F library was much tighter than the distribution of the
insulated J23100 libraries for all tested upstream MoClo fusion sites. The GFP ex-
pression fold change of the reference circuit was 6.28x. Insulated pBAD F cassettes
showing a fold change greater than 10x are depicted by the orange bars in Figure
5.7. Two distinct but equivalent DNA spacers from the candidate spacers with GFP
induction levels identical to that of the reference device were selected for insulating
the two instances of the pBAD promoter in our 24 inverter permutation sets.
5.2.4 Distribution of PCR-generated 36nt-insulated pTet library
Unlike the promoter J23100 and pBAD, the repressible promoter pTet in isolation
was found to be unaffected by variations in the DNA sequence at its 5’ boundary.
As a template for spacer library generation, I selected an inverter configuration
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where the pTet promoter was flanked by the MoClo fusion site “A” (5’-GGAG), and
the J23100 and pBAD promoters were insulated. The inverters were grown overnight
in LB Broth as described in Chapter 3 and then grown for a second night in the
presence (ON state) or absence (OFF state) or 1 mM L-arabinose. The inverters
were diluted in 1x Phosphate Buffered Saline (PBS) as described in Chapter 3,
section 3.3.2 and the expression of green and red fluorescence was measured by flow
cytometry. All samples were tested in triplicate. Fluorescence measurements were
converted to absolute units (MEFLs) using the TASBE Tools [7, 9].
Figure 5.8 shows the distribution of RFP expression of insulated pTet promoters
created within the context of a full inverter circuit. As RFP is inhibited when
the inverter is induced with L-arabinose, a good candidate DNA spacer should not
diminish RFP repression of the template inverter. RFP fold change on inverter
induction of the template/reference circuit was 6.2x (red bars); the orange bars
indicate the insulated pTet circuits with >10x repression of RFP expression upon
induction. The distribution of RFP expression of the insulated pTet promoters was
very wide and did not contain a clear single peak. Upon induction, in many insulated
pTet promoters the RFP expression increased instead of decreasing upon induction.
In several cases, RFP expression remained unchanged. However, in some devices,
in over a tenth of the devices sampled, we observed that the inserted DNA spacer
actually increased RFP repression upon induction of the inverter (see Figure 5.8(c)).
I received assistance from our collaborator in creating a visual representation of
the insulated pTet promoter library.
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5.3 Discussion
The wide distribution of insulated J23100 promoter expression shows that it may
not be possible to rationally design truly neutral DNA spacers that provide precisely
the level of insulation required without undergoing exhaustive trial and error. For
minimal promoters like the BioBricks J231XX series [34] that are defined as the -35
and -10 RNA Polymerase (RNAP) binding sequences with an intervening 17 base pair
sequence without any buffering sequences 5’ of the -35 RNAP binding site, the use of
insulated promoters may be critical to obtaining expression matching the promoter
characterization data when recomposed into a larger synthetic genetic device.
5.3.1 Designing DNA spacers of alternate lengths
In my preliminary work on DNA spacers I show that 36 base pair spacers are sufficient
for insulating promoter J23100. However, given the wide variation of expression levels
of insulated DNA spacers observed during screening candidate spacers, it is evident
that I was fortunate in my original selection of the two 36 base pair DNA spacers
to test. It is quite possible that other lengths - both shorter and longer - can also
provide reliable and precise promoter insulation.
Procedurally, there are no barriers to designing 100% degenerate DNA spacers of
lengths shorter than 36 base pairs. Shorter DNA spacers can be obtained simply by
reducing the number of degenerate nucleotides in each primer to one half of the final
desired spacer length. However, there is a upper limit on the length of the spacer
that can be inserted upstream of a promoter. The maximum length of a DNA spacer
possible using this method is 50 nucleotides. This limitation is not due to the method
itself; the current available DNA synthesis technologies do not allow companies to
synthesize a stretch of 100% degenerate nucleotides longer than 25 nucelotides at the
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moment. As technologies improve, longer DNA spacers will become possible. The
cost of primers can also be reduced by using DNA spacers shorter than 36 base pairs.
5.3.2 Resource Cost of Insulating a Promoter
The most significant costs involved in insulating a promoter are the cost of primers,
which are unlikely to be re-usable in a new context, as well as the time in lab that is
required to generate the DNA spacer library and perform the screening. The biggest
cost in insulating a promoter is the cost of the polyacrylamide gel electrophoresis
(PAGE)-purification to each promoter in its final context. PAGE-purified primers
are recommended for modified oligonucleotides (oligos) as well as oligos that are 60
nucelotides or longer. PAGE-purified primers cost $110.0 per primer. However, it is
possible to obtain a library of DNA spacers using cheaper HPLC-purified primers,
bringing the cost of oligonucleotide primers down from $110.0 per primer to $40.0
per primer. Whether or not the distribution of expression of the spacer library
obtained using HPLC-purified primers is different from that obtained using PAGE-
purified primers has not yet been tested. Similarly, commercially prepared chemically
competent cells (See Chapter 3) were used for transformation of the DNA spacer
library. Transformations can be done more cheaply using homemade competent
cells. The cost of insulating a single promoter as per the protocols in this thesis are
provided in Table 5.1.
The process of generating an insulated promoter library and performing the screen
for a DNA spacer adds 8-10 days to the build cycle before the testing phase, depend-
ing on the type and length of induction necessary, not including the time required
to order a new promoter part with the DNA spacer selected by screening. The min-
imum time required to obtain a DNA spacer by the spacer library generation and
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Table 5.1: Approximate reagent cost to insulate a promoter.
Reagent Cost
Primers (PAGE-purified) $220
PCR reagents $4.24
PCR template
elimination (Dpn I)
$1.55
Ligation $0.32
Transformation
(commercial, chemically
competent cells)
$8.60
screening protocols in this thesis is 8 days (constitutive promoters). For promoters
that had to be tested with and without an inducer, the process added 10 days to
the protocol. A breakdown of the time taken by intermediate steps is provided in
Table 5.2. Reducing the overnight ligation step results in <10x fewer colonies post-
transformation and is not recommended. Reducing the DpnI digestion is possible but
not recommended to ensure that the insulated promoter library is not contaminated
with uninsulated template sample.
Table 5.2: Approximate time cost to insulate a promoter
Protocol Time
PCR 1 day
Dpn I restriction digest 1 day
Ligation 1 day
Transformation 1 day
Screening 2-3 days
Plasmid purification 1 day
Sequencing 1 day
The time required for ordering/synthesizing a new insulated promoter part was
not be included as the time required will vary depending on the size of the insulated
promoter part and the method of part creation. For example, insulated minimal
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promoters ordered as as ultramer oligonucleotides and then annealed to create the
cloning-ready promoter part can take as few as 3 days. However, a longer insulated
promoter part that must be ordered as a gblock will take, at a very minimum, 12
days to be available for cloning.
5.3.3 Transferring the randomized spacer screening methodology to other
organisms
Fluctuating promoter expression as a result of changing DNA sequence at promoter
5’ junctions has been extensively studied in E. coli. However, the problem has been
known to exist in other organisms as well (word of mouth from Prof. Karmella
Haynes, Arizona State University, at the Synthetic Biology Engineering Research
Center Spring Retreat 2015). Synthetic promoter parts in other host organisms may
also benefit from insulation against their upstream sequences. Procedurally, there
are no barriers to transferring the DNA spacer generation and screening methodology
to unidirectional promoter parts in other species of bacteria, as well as in yeast and
even mammalian systems. No modifications to the methodology need to be made.
Insulated promoter libraries can be grown for screening using the standard growth
protocols for flow cytometry for that species and type of promoter. DNA spacers
can be inserted upstream eukaryotic minimal and other constitutive promoters in
exactly the same way as in the bacterial constitutive promoter (See Figure 5.1).
In mammalian regulated promoters the DNA spacer methodology could serve the
additional purpose of adjusting promoter expression levels without having to change
the locus of cloned regulator elements (such as enhancer or repressor elements), thus
reducing the number of design, build test cycles. However, the spacer screening
methodology cannot be applied to bidirectional promoters [55, 69]. Bidirectional
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promoters are short (<1kb) regions of intergenic DNA between the 5’ ends of two
divergent genes on either strand of DNA. The intergenic region serves as a promoter
element for both genes and adding a spacer of either side of the promoter would
disrupt transcription initiation from the gene on the opposite DNA strand.
5.3.4 Generating improved context-independent variants of commonly
used BioBricks promoters
As I show in the next chapter (Chapter 6, Figure 6.2.4) that a screened DNA spacer
selected to eliminate DNA sequence context dependence of one upstream cloning scar
also successfully eliminates expression variations caused by a different cloning scar.
It should thus be possible to undertake the screening process for each promoter only
once and generate new, improved versions of well-studied promoter parts that behave
predictably regardless of variations in DNA sequence at the 5’ promoter junction. I
am making the insulated J23100 promoter, two insulated pBAD promoters (insulated
with two distinct but equivalent DNA spacers) and one insulated pTet promoter
publicly available through the iGEM BioBricks Parts Registry[35] as well as through
Addgene [1].
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Figure 5.4: Distribution of insulated 36nt-J23100 K GFP library. Expression
of approximately 400 samples from the 36nt-J23100 K spacer library were checked
by flow cytometry for GFP expression levels. The orange bar marks the expression
level of insulated J23100 K cassettes with the same expression level as the uninsu-
lated J23100 A-GFP reference circuit. The expression distribution contained a clear
peak. Samples expressing GFP at that same level as the J23100 A reference circuit
fell at the lowest end of the distribution of expressions and was lower than peak
insulated cassette expression. All fluorescence readouts were converted to absolute
units (MEFLs).
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Figure 5.5: Visualization of sequence weighting in sequenced 36nt spac-
ers from 36n-J23100 X libraries. 150 36nt spacer sequences from J23100 A,
J23100 E and J23100 K were analyzed for consensus bases and motifs using the We-
bLogo 2.8.2 tool [14]. The base at the final position of all sequenced spacers was
found to be (deoxy)thymine in 60% of sequenced spacers.
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Figure 5.6: Sequence overlap distribution for all sequenced DNA spac-
ers. Among the 150 36nt spacers from J23100 A, J23100 E and J23100 K plates se-
quenced, anomalous enriched presence of any one spacer sequence was not observed.
Most sequenced spacers had approximately 9 identical bases. Only 2 duplicate spac-
ers were found among the 150 sequenced spacers.
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Figure 5.7: Distribution of pBAD F GFP library insulated with 36nt DNA
spacers Expression of approximately 200 samples from the 36nt-pBAD F spacer
library were checked by flow cytometry for GFP expression levels in the presence and
absence of 1mM L-arabinose. The library was then compared to the reference device
expression (red). Devices with >10x GFP expression are denoted in orange. (a) GFP
expression of uninduced insulated pBAD F-GFP circuits. (b) GFP expression of
induced insulated pBAD F-GFP circuits. (c) Log10 fold change of sampled insulated
pBAD F-GFP library on induction. All fluorescence readouts were converted to
absolute units (MEFLs).
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Figure 5.8: Distribution of pTet A RFP library insulated with 36nt DNA
spacers Expression of approximately 200 samples from the 36nt-pTet A spacer li-
brary were checked by flow cytometry for RFP expression levels in the presence and
absence of 1mM L-arabinose. The library was then screened against the reference de-
vice expression (red bar). Devices with >10x RFP repression are denoted in orange.
(a) RFP expression of uninduced insulated pTet A-RFP circuits. (b) RFP expression
of induced insulated pTet A-RFP circuits. (c) Log10 fold change of sampled insu-
lated pTet A-RFP library on induction. All fluorescence readouts were converted to
absolute units (MEFLs).
Chapter 6
DNA Spacers: Component order
independence and precise expression
control through the use of empirically
selected DNA spacers
6.1 Introduction
In this chapter, I validate the utility of my spacer screening methodology by using
the DNA spacers that I obtained through the J23100 E and pBAD F used them
to in the previously chapter and sequentially insulate the promoters within my 24
inverter permutation set (for inverter permutation circuit architecture, please see
Figure 4.1). First, I show the 24 inverter set with either only J23100 or only pBAD
insulated in each transcription unit permutation of the inverter (Figure 6.1 and
Figure 6.2.2). In each case, it would be reasonable to expect that insulating one or
the other affected promoter in the 24 inverter set corrects some, but not all anomalous
device expression profiles (where expression either violates the NOT gate truth table,
or fails to express entirely). Then, I insulate both affected promoters J23100 and
pBAD at once. If my spacer screening methodology is robust, and if the majority
of the anomalous expression is a result of the DNA sequence variations at the 5’
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boundaries of promoters, then insulating just only J23100 and pBAD should correct
anomalous expression.
Finally, selecting a DNA spacer from the pTet screen that improves the RFP
repression upon inverter induction with L-arabinose, I would expect to see an im-
provement in the RFP fold change (greater repression) in the 24 inverter set in which
all promoters are empirically insulated.
6.2 Results
6.2.1 Empirically insulating constitutive promoter J23100 in 24 inverter
set improves overall device performance and reduces DNA sequence-
based order dependence
Following the selection of a spacer sequence from the J23100 insulated GFP cassette
screen (Figure 5.2), I replaced the J23100 promoter in all 24 permutations of my
test inverter with an insulated version of J23100. The DNA spacer insulating the
promoter was obtained from the set of DNA spacers that produced GFP expression
levels identical to that of the uninsulated J23100 A in isolation. The inverters were
assembled using MoClo DNA assembly and were grown overnight in LB Broth as
described in Chapter 3. They were then grown for a second night in the presence (ON
state) or absence (OFF state) or 1 mM L-arabinose. The inverters were diluted in
1x Phosphate Buffered Saline (PBS) as described in Chapter 3, Section 3.3.2 and the
expression of green and red fluorescence was measured by flow cytometry. All samples
were tested in triplicate. Fluorescence measurements were converted to absolute
units (MEFLs) using the TASBE Tools [7, 9]. Insulating J23100 resulted in an
increase in the fraction of devices with >10x GFP and RFP induction and repression,
respectively. No inverters demonstrated an anomalous pattern of expression relative
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to the expected NOT-gate expression truth table. Five out of 24 of the J23100-
insulated 24 inverter set failed to show any fold change.
6.2.2 Insulating inducible promoter pBAD in 24 inverter set improves
overall device performance and reduces DNA sequence-based order
dependence.
Following the selection of a spacer sequence from the pBAD F insulated GFP cassette
screen, we rebuilt the 24 inverter set with new insulated pBAD parts (see Figure
6.2.2). All instances of the pBAD promoter in each inverter were insulated. We
measured the GFP and RFP fluorescence in the ON (induced, 1mM L-arabinose)
and OFF (uninduced, 0 mM L-arabinose) states. Insulating pBAD resulted in an
increase in the fraction of devices with >10x GFP and RFP induction and repression,
respectively. No inverters demonstrated an anomalous pattern of expression relative
to the expected NOT-gate expression truth table. Five out of 24 of the J23100-
insulated 24 inverter set failed to show any fold change.
6.2.3 Co-insulating promoters J23100 and pBAD in the 24 inverter set
eliminates upstream promoter DNA sequence-based order depen-
dence
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Expression profile of 24 inverter set with promoter J23100 insulated em-
pirically upon induction with 1mM L-arabinose. GFP and RFP fold change
upon L-arabinose induction of J23100-insulated 24 inverter set. DNA spacer sequence
was obtained by screening the 36n-J23100 E library against J23100 A. Insulated pro-
moters are denoted in the device key by small gray boxes placed between the purple
box denoting J23100-AraC and its upstream MoClo fusion site. Insulation of J23100
resulted in a smaller fraction of both devices that fail or behave anomalously. Inter-
estingly, out of the 8 devices that either failed or had an expression pattern violating
the NOT-gate truth table, 6 devices contained pBAD F with either GFP or TetR as
the CDS. All fluorescence readouts have been converted to absolute units (MEFLs).
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Insulating promoter pBAD with screened DNA spacer reduces context
dependence and improves overall inverter performance. GFP and RFP fold
change upon L-arabinose induction of pBAD-insulated 24 inverter set. DNA spacer
sequence was obtained by screening the 36n-pBAD F library against pBAD A. Insu-
lated promoters are denoted in the device key by small gray boxes placed between the
upstream MoClo fusion site and the blue and green boxes denoting pBAD-TetR and
pBAD-GFP TUs, respectively. Insulation of J23100 resulted in a smaller fraction of
both devices that fail or behave anomalously compared to the uninsulated 24 inverter
set. All fluorescence readouts have been converted to absolute units (MEFLs).
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Figure 6.2.3 shows the 24 inverter set where both constitutive promoter J23100
and inducible promoter pBAD were insulated. The insulated J23100 promoter ob-
tained from the J23100 E screen and used above (Figure 6.1). The insulated promot-
ers used in Figure 6.2.2 and Figure 6.1 (obtained from the spacer screen performed
on pBAD F and J23100 E (Figure 5.7 and Figure 5.2)) were reused to insulate pBAD
in the co-insulated 24 inverter set. Using these insulated promoter parts, I rebuilt
the 24 inverter set using MoClo DNA assembly. All instances of promoters J23100
and pBAD in each inverter were insulated. The inverters were grown overnight in LB
Broth as described in Chapter 3 and then grown for a second night in the presence
(ON state) or absence (OFF state) or 1 mM L-arabinose. The inverters were diluted
in 1x Phosphate Buffered Saline (PBS) as described in Chapter 3, Section 3.3.2
and the expression of green and red fluorescence was measured by flow cytometry.
All samples were tested in triplicate. Fluorescence measurements were converted to
absolute units (MEFLs) using the TASBE Tools [7, 9].
We measured the GFP and RFP fluorescence in the ON (induced, 1mM L-
arabinose) and OFF (uninduced, 0 mM L-arabinose) states. Both J23100 and pBAD
promoters previously demonstrated upstream DNA sequence context dependence
with MoClo fusion sites “E” and “F” for promoter J23100 and fusion site “F” for
promoter pBAD. On co-insulating both promoters, all 24 devices performed as ex-
pected for a NOT-gate. Moreover, a greater fraction of inverters demonstrated >10x
change in both GFP and RFP expression, resulting in better dynamic range of input
and output.
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6.2.4 Insulating all promoters with custom-screened DNA spacers im-
proves overall device performance and increases the fraction of
devices performing as expected
When tested in isolation, the pTet promoter was found to be robust and unaffected
by its upstream DNA sequence (Figure 4.8). The 36nt-pBAD DNA spacer screen
was applied to screen for spacers that would provide greater pTet repression on
insulation. A DNA spacer providing 10x repression was selected and an insulated
pTet promoter generated. The 24 inverter set was rebuilt with all insulated promoters
from the screen. The inverters were grown overnight in LB Broth as described in
Chapter 3 and then grown for a second night in the presence (ON state) or absence
(OFF state) or 1 mM L-arabinose. The inverters were diluted in 1x Phosphate
Buffered Saline (PBS) as described in Chapter 3, Section 3.3.2 and the expression of
green and red fluorescence was measured by flow cytometry. All samples were tested
in triplicate. Fluorescence measurements were converted to absolute units (MEFLs)
using the TASBE Tools [7, 9].
Insulating pTet in addition to J23100 and pBAD does not alter the upstream
sequence-related context independence achieved by insulating only the J23100 and
pBAD promoters. Furthermore, insulating the pTet promoter increased the fraction
of inverters that demonstrated >10x decrease in RFP expression on L-arabinose
induction. Finally, as expected, insulating the pTet promoter did not significantly
affect the GFP expression fold-change.
In a 24 inverter set with both J23100 and pBAD simultaneously insulated via
our method, no devices behaved anomalously (Fig. 6.1) and the fraction of invert-
ers showing a 10x fold change for both GFP and RFP also increased. Using an
insulated pTet promoter from our screen in conjunction with J23100 and pBAD did
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not cause anomalous behavior of any inverters (Fig. 6.1). Furthermore, as expected,
insulating pTet improved RFP fold change (Fig. 6.2.4) without impacting GFP fold
change, as candidate pTet spacers with off target effects were eliminated through the
spacer screening process. Finally, the 24 inverter set with all promoters insulated
demonstrate the highest number of devices with > 10x RFP repression on arabinose
induction.
Figure 6.1 demonstrates the observed improvement of GFP expression perfor-
mance as a function of the number of empirically-insulated promoters included in
the inverter design. For uninsulated inverters (pink), only 10% of the 24 inverters
showed in five instances a 10x induction in GFP expression on L-arabinose induction.
In inverters where only either promoter J23100 (blue) or pBAD (green) was insu-
lated, under 30% and under 40% of inverters were observed to show a 10x increase
in GFP expression upon L-arabinose induction. In contrast, in inverters where both
promoters J23100 and pBAD were insulated simultaneously (red), approximately
50% of all inverters could be showed a 10x increase in GFP expression. This number
increased, but not substantially, when all promoters were insulated (black), which is
not surprising as promoter pTet controlled RFP expression and insulating promoter
pTet should not impact GFP expression significantly.
Figure 6.1 demonstrates the observed RFP repression profile improvement as a
function of the number of empirically-insulated promoters included in the inverter
design. No uninsulated inverters (pink) are expected to show a 10x repression of
RFP expression on L-arabinose induction. Furthermore, almost 60% of all uninsu-
lated inverters are expected to show no RFP repression upon induction. In contrast,
100% of all-insulated (black) or promoters J23100 and pBAD simultaneously insu-
lated (red) inverters are expected to show some RFP repression when inverter circuits
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are insulated. A greater area under the graph represents better overall performance.
Whereas all-insulated (black) and J23100- and pBAD-only (red) insulated sets con-
tained near-identical areas under their respective curves in the GFP expression profile
(Figure 6.1), the all-insulated set (black) in the RFP performance profile contains
more area under the curve than that under the J23100 and pBAD-only (red) curve,
demonstrating that insulating the pTet promoter improved the pTet performance
specifically without impacting the GFP expression profile.
6.3 Discussion
Part-junction interference at the 5’ boundaries of promoters is unavoidable if they
are to be composed into complex devices. Even small variations in the DNA sequence
at the 5’ boundaries of promoters can greatly alter promoter performance leading
to design failures of composed genetic circuits. There does not appear to be any
standardized set of rules for selecting DNA spacer sequences that provide reliable
insulation without itself affecting promoter expression. We provide a method for
generating and screening a library of insulated promoters within the context of the
target device for precise expression control that we show to work for constitutive,
inducible and repressible promoters.
Given the very large range of expression levels observed in the sampled J23100
and pTet insulated promoter libraries, it is unlikely that designing a DNA spacer
that provides reliable insulation without itself affecting promoter expression can be
achieved without extensive testing. A DNA spacer that reliably insulates one pro-
moter may not work when inserted upstream of a different promoter. Given the
ability of our method to generate and screen in the context of the target device,
our method has the potential to be used as a tool for fine-tuning circuit expression
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without having to swap out promoters and RBSs. It could also potentially be used
to increase the separation of reporter expressions between ON and OFF states in
binary logic devices.
The distribution of expression for screened insulated pBAD promoters (Fig-
ure 5.7) was found to be much tighter than that for promoters J23100 and pTet
(Figures 5.2 and 5.8). It is possible that for a tested promoter, the distribution of
insulated promoter expression will not span the required expression range needed.
In such a case, swapping promoter/RBS parts may become unavoidable. In every
case here, we used a reference device to screen candidate insulated promoter circuits
against. In the absence of a reference, our method has no level to match, but can still
achieve precise expression control, but would still be useful for eliminating candidate
DNA spacers that abolish expression or cause unanticipated off-target effects. Ap-
plying our method to genetic circuits in which component modules are on different
plasmids requires a more laborious and circuitous route than we have outlined, and
has not yet been tested.
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Expression profile of the 24 inverter set with promoters J23100 and pBAD
insulated empirically upon induction with 1mM L-arabinose. GFP and
RFP fold change upon L-arabinose induction of 24 inverter set in which promoter
J23100 and promoter pBAD are insulated. DNA spacer sequences were obtained
from the 36n-J23100 E and 36n-pBAD F screens. Insulated promoters are denoted
in the device key by a small gray box placed between the purple, blue or green box
denoting J23100-AraC, pBAD-TetR and pBAD-GFP, respectively, and its upstream
MoClo fusion site. Simultaneous insulation of known affected promoters completely
eliminates genetic context-based order dependence.
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Expression profile of the 24 inverter set with promoter all promoters in-
sulated empirically upon induction with 1mM L-arabinose.(Continued from
previous page.) Insulating the upstream DNA context-independent promoter pTet
improves inverter performance. GFP and RFP fold change upon L-arabinose induc-
tion of J23100, pBADand pTet-insulated 24 inverter set. DNA spacer sequences were
obtained from the 36n-J23100 E, 36n-pBAD F and 36n-pTet A screens. Insulated
promoters are denoted in the device key by a small gray box placed between the
purple, blue, green or red box denoting J23100-AraC, pBAD-TetR, pBAD-GFP or
pTet-RFP, respectively, and its upstream MoClo fusion site. Selecting a DNA spacer
from 36nt-pTet screen that provided a >10x repression on L-arabinose induction
improves the RFP fold change in the 24 inverter set.
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Chapter 7
DNA Assembly Automation:
Development and validation of liquid
classes for automated DNA assembly on a
Tecan liquid-handling robotic platform
7.1 Introduction
As they grow in size and complexity, designing, building, organizing, tracking and
managing genetic devices and device-variants manually becomes both error-prone
and time-prohibitive. A four-part expression module consisting of a promoter, RBS,
Coding Sequence (CDS) and terminator and lacking any logical computation and
built from a modest part library comprising 25 promoters, 5 RBSs, 5 CDSs and 1
terminator has 625 possible valid devices. When engineering genetic devices com-
prising multiple intermediate modules, additional variations involving orientation of
promoters relative to each other further increases the size of the design space. As
such, manually assembling DNA is impractical, inefficient, and highly error-prone.
Standardized and efficient, multi-part DNA assembly methods [68, 38, 20, 44, 19, 63]
combined with computational DNA assembly planning tools [6] can help make DNA
assembly more efficient, but even multiplexing-friendly DNA assembly methods [38]
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cannot be solely managed manually. Commercial DNA synthesis presents an alter-
native to manual DNA assembly in the lab, but the cost of DNA synthesis is still
prohibitive as the only DNA synthesis strategy is too high to replace manual DNA
assembly in research labs. As such DNA assembly is often the rate-limiting step in
synthetic genetic workflows and would greatly benefit from being automated.
7.1.1 Existing automation in synthetic biology
Automation in synthetic biology is not a novel idea. Computational tools automat-
ing individual steps in the specify-design-build-test workflow already exist [66, 12],
and new tools are continuously being added and existing tools being improved upon.
Synthetic biology data management frameworks such as Clotho [70] are also being
developed as platforms providing an end-to-end automated processing of all specifi-
cation and design steps in a synthetic biology workflow allowing for seamless man-
agement of bioengineering design and analysis. Other end-to-end workflows like the
Tool-Chain to Accelerate Synthetic Biology Engineering (TASBE) [8] also attempt
to automate the engineering workflow of biology. The biological design specifica-
tion language EUGENE automatically generates the possible biological designs for
assembly from a user-defined library of genetic parts and applies any user-desired
assembly constraints to the design space [53, 54, 10, 17].
The physical assembly of DNA parts has remained, since the beginning, a major
broken link in synthetic biology research automation. Multiple automated tools exist
for most other steps in the synthetic biology workflow: A formally expression logic
function can be automatically converted into biological designs using defined parts
and part features [42]. These parts can be automatically mapped to characterized
physical DNA samples stored in part repositories. Target circuits and genetic devices
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can be automatically created by mapping these parts and features on to DNA back-
bones to create plasmids, which are then stored in sample tracking and management
systems [60, 15] and can be processed in bulk automatically. Tools exist for gen-
erating automated assembly plans for constructing devices to generate the physical
samples for the devices that the design abstraction tools have built, and even provide
users their choice of one or a combination of the most-used DNA assembly methods
[6]. Once the samples are generated – mostly manually – they can be tested using
high-throughput samplers attached to flow cytometers. Their data can be automat-
ically processed and analyzed [8]. New machine-learning tools are even available
to automatically rank the collected data from the devices using user-defined rank-
ing parameters [61]. Furthermore, tools exists for automatically generating physical
representations of standards-compliant design visualizations [24].
7.1.2 Current state of DNA assembly automation
Until the advent of synthetic biology and biological part repositories such as Joint
BioEnergy Institute (JBEI)-ICE Registry [31], the CIDAR-ICE repository [56] and
the public genetic parts repository, Registry of Standard Biological Parts maintained
by the International Genetically Engineered Machine (iGEM) Foundation [35], ge-
netic parts were not stored in any standardized format. Only a small handful of
parts needed to be cloned per project, and thus, the volume of cloning done was
not very large, these were not big hurdles in the realization of actual research aims.
Molecular cloning was always done ad hoc by performing restriction digests using
whatever restriction endonuclease sites were available flanking the part of choice.
The lack of standardization made it impractical to automate any cloning protocol
as it was unlikely that the next cloning reaction would follow an identical protocol.
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Furthermore, automating DNA assembly required significant monetary investment
in equipment (liquid handling robots and their associated paraphernalia) as well
as the time investment for the generation of instructions to develop accurate pa-
rameters for handling the various classes of liquids being processed and the precise
series of instructions to run these protocols. It would be impractical to make these
investments when DNA assembly was not the bottleneck in the research pipeline.
The mindset that DNA assembly is an achievement of intensive labor rather than
efficiency remained ingrained even after the advent of synthetic biology and even
researchers have been much slower in recognizing the pressing need for automation
of DNA assembly compared to other steps in the synthetic biology workflow. As a
result, DNA assembly automation lags behind the automation of other steps in the
synthetic biology pipeline in spite of often being the bottleneck in the number of
synthetic devices being built and tested.
Furthermore, not all steps in molecular cloning are easily automatable: selecting
and picking clones from a transformation plate post-cloning involves many complex
decisions that take a human with fundamental knowledge in molecular biology and
basic lab training a matter of seconds to minutes, but involve too many complex
decision-making processes that cannot be taught to a machine at the current state of
the art. However, sample-tracking and liquid-handling steps are easily automatable
and also constitute a major source of human error in manual DNA assembly
Nonetheless, partial automation of laboratory protocols that are essential to car-
rying out DNA assembly have been developed: Qiagen, a leading vendor of DNA
extraction and purification kits, also sells its “off-the-shelf” bench top robot for ex-
ecuting only its own protocols. However, it processes only 12 samples at a time,
is not customizable, and is slower than manual execution of these protocols. Ven-
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dors of liquid-handling robotic systems have also developed protocols for carrying
out DNA extraction and purification using their robotic technology. While these are
much higher-throughput and also fast, they are proprietary and are only available as
supplementary purchases over and above the price of the liquid-handling robot itself.
7.2 Optimizable Liquid Class Parameters
Section 7.3 provides comprehensive listings of all the optimized liquid class parame-
ters that I made to increase the automated MoClo DNA assembly reaction efficiency
from 0% to approximately 98%. To understand the changes to the liquid classes I
have made the following list, obtained from the Tecan [37] EVO 150 reference man-
ual, provides a description of the function of each liquid class parameter. Parameter
descriptions listed blow in Section 7.2 are either paraphrased or reproduced from
Tecan EvoWare user guide. [37].
7.2.1 Liquid Class Parameters
Aspiration Speed: Speed at which liquid is drawn into the pipette arm. Aspiration
speed is set in µL/s. A lower aspiration speed can improve the pipetting accuracy,
especially for viscous liquids. A higher aspiration speed improves the speed of oper-
ation.
Delay: Specifies the time the pipette is held in aspirate position before being re-
tracted to “Retract to” position. Specified in ms.
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System Trailing Airgap (STAG): Specifies the volume of air separating the sys-
tem liquid from the sample being aspirated and dispensed.
Leading Airgap (LAG): The air in the leading airgap is dispensed together with
the net sample volume in the Dispense command. The resulting tip blowout leads to
more accurate pipetting. The LAG creating additional buffering between the sample
and the system liquid although that is not its primary purpose. Specified in µL.
Trailing Airgap (TAG): The trailing air gap specifies an additional, user-defined
volume of air to be aspirated into the pipette tip after aspirating the specified sample
volume. The TAG is used to prevent liquid dripping from the tip when the robotic
arm moves. In addition, it ensures that the liquid meniscus is not dragged away from
the end of the tip during fast movements. Specified in µL. The TAG is aspirated
at the Z-position specified with the Retract Tips to. A Z-position relative to the
liquid level requires liquid level detection and must not be used when carried out
with septum-piercing as the septum interferes with the capacitance-based liquid de-
tection system and results in TAG being aspirated while the tips are still in the liquid.
Excess Volume: Used to specify excess volume of sample aspirated in addition
to the volume specified in the experiment parameters. The purpose of the excess
volume is to reduce the contamination of the sample liquid in the tips with the sys-
tem liquid to an absolute minimum. If excess volume is specified, a destination for
discarding excess volume must also be specified (for example, Discard to waste, or
Back to vessel). Specified in µL or as %
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Conditioning Volume: The conditioning volume can be used to maximize pipet-
ting accuracy by ensuring that the liquid meniscus at the end of the tips is the same
shape as after aspirating as it will be after dispensing. The conditioning volume is
discarded directly after aspirating. If a conditioning volume is specified, a destina-
tion must also be specified for it to be discarded (for example, Discard to waste, or
Back to vessel). Specified in µL or as %
Use Pinch Valve: This is used to activate the Low Volume option if it is fitted to
the pipetting instrument. Works with only the first pipette tip.
Use Liquid Detection: This activates liquid level detection using a capacitative
liquid level detection (cLLD) when aspirating. cLLD detects the surface through a
change in the electrical capacitance of the pipetting tip when the tip enters the liquid.
It is carried out just before aspirating and can be used to minimize tip contamination
by reducing the tip immersion depth. A minimum volume of 30 µL in excess of the
volume to be used in the reaction is required in each well for liquid level detection
for water, enzyme buffers and DNA. For viscous liquids like enzymes, an even larger
volume of liquid is needed to account for the liquid loss due during pipetting steps.
This volume is referred to as “dead volume”. cLLD does not work well with liquid
samples that do not contain adequate dissolved solutes, such as deionized water, Us-
ing cLLD with deionized water produces a non-fatal error during protocol execution.
On Detection Error: Specifies the error-handling if Freedom EVOware detects no
liquid or not enough liquid. The error-handling mode User prompt shows the Liq-
uid Detection Error dialog; the other 3 options carry out the chosen error-handling
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action directly and do not show the Liquid Detection Error dialog.
Use Exit Signal Detection: Activates capacitive exit signal detection (dip out
signal detection). This detects the liquid surface through a change in the electrical
capacitance of the pipetting tip when the tip is retracted and exits the liquid. It is
carried out just after aspirating. The measured liquid level is then compared with
the liquid level that should have resulted from the aspiration. This can only be ac-
tivated if liquid level detection has been enabled.
On Exit Signal Error: Specifies the selected required error-handling if the exit
signal error does not take place as expected when retracting the tips. Currently
reported in the report file from the Export Data command.
On PMP Clot Error: Allows selection of the required error-handling if a clot is
detected using the pressure-based clot-detection system, which requires the PMP
hardware option available only for Liquid-Handling (LiHa) Disposable Tips (DiTi).
Aspiration position: Specified by the Z-position and the Z-offset of the tips when
aspirating. A positive value for the offset lowers the tips. If liquid level detection
is being used, only z-positions relative to liquid level can be specified. X- and Y-
positions can also be specified when aspirating.
Mix before Aspiration: This option specifies that Freedom EVOware is to mix
the liquid before aspirating. The number of mix cycles can range between 1 and 99
and the mix volume can range between 1 and 2500 µL. The Z-position and Z-offset
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can be specified by the user. A positive value for the offset lowers the tips.
Retract Tips to: Specifies the Z-position and the Z-offset to which tips should
retract (move upwards) to after.
7.2.1.1 Adjustable parameters in Tecan Evo Liquid-handling robot Liq-
uid Class Dispense protocol:
The following are the available parameters of movement and air-displacement of the
disposable pipette tip that can be customized executing dispense parameters in an
air-displacement Tecan liquid-handling robot. Figure 7.1 provides a screenshot of
the dispense parameter setup screen within the Freedom EVOware software. The
following parameter descriptions were either paraphrased or reproduced from the the
Tecan EVOware user guide [37].
Dispense Speed: Specifies the speed at which aspirated sample liquid is released
into the destination well. A high dispense speed is needed to achieve a proper free
dispense. However, the dispense speed must be lowered when handling liquids of
high viscosity. the maximum dispense speed is about 80% of the syringe size (dilutor
capacity) per second. The dispense speed is specified as µL/s
Breakoff Speed: Specifies the final destination speed (breakoff) of the sample liquid
from the pipette tip. The breakoff speed should normally be about 70% of the actual
dispense speed but should not exceed 45% of the syringe size (dilutor capacity) per
second. A high breakoff speed is necessary to achieve a proper free dispense. The
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Figure 7.1: Screnshot of Dispense liquid class optimization panel in the Tecan
EVOware software. Parameters must be adjusted for very-small (1.5 - 3.0µL), small
(3.0 - 5.0 and 5.0 -15.0 µL), mid-ranges (15.0 - 200 µL) and large (>200 µL) volume
ranges for all liquid with dissimilar viscosity.
break off speed is specified as µL/s.
Delay: Specifies the time for which the pipette tip remains in the dispense position
before retracting to the Retract Tips to position. Specified in ms.
Trailing Airgap after each Dispense: Allows for automatic aspiration of a
Trailign Airgap (TAG) after each dispense. These parameters are specified in the
Aspirate dialog box.
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Use Pinch Valve: This is used to activate the Low Volume option if it is fitted to
the pipetting instrument. Works with only the first pipette tip.
Use Liquid Detection: This activates liquid level detection using a capacitative
liquid level detection (cLLD) when dispensing. cLLD detects the surface through
a change in the electrical capacitance of the pipetting tip when the tip enters the
liquid. cLLD when dispensing can be used to ensure that the pipette tip remains
immersed in liquid during dispensing and is a useful parameter for dispensing very
small volumes of liquids.
Dispense Position: Specifies the Z-position and the Z-offset of the tips when dis-
pensing. A positive value for the offset lowers tips. If Liquid Level Detection is
activated, the Dispense Position has to be specified relative to liquid level. If track-
ing is selected, the tips will move upwards as the liquid level rises in the wells during
dispensing. This option minimizes contamination by restricting the depth to which
the pipette tip is immersed into the sample.
Tip Touching: Activating Tip Touching during the Dispense command dispenses
the liquid in the normal way, but then moves the tip to the side of the well and
back before retracting them, mimicking manual dispense actions. This helps remove
any droplets of liquid which may be adhering to the tips. This is effective when
dispensing small volumes of liquid into an empty destination well. The direction of
Tip Touching can be specified.
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Speed:Specifies the Tip Touching speed in mm/s
Delay after touching:Specifies the delay between tip touching the well and moving
back to the middle of the well.
Mix after Dispense: Allows the user to mix the pipetted sample after dispensing
it. The number of mix cycles (range: 1 to 99) and the mix volume (range: 1 to 2500
µL) can be specified.
Retract Tips to: Specifies the Z-position and the Z-offset to which the tips should
retract (move upwards) after dispensing. A positive value for the offset lowers the
tips. If Liquid Level Detection has been activated, then only positions relative to
liquid level can be specified.
Retract Speed: Specifies the required retract speed in mm/s.
7.2.2 Global Liquid Class Settings
The following settings apply to all liquid classes and pipetting steps for the Tecan
Evo 150:
• First pipette tip: The first pipette tip on the Tecan Evo 150 is never used for
any reaction setups.
• Pinch Valve Set to Off: This affects only the first pipette tip so is set to be off
for all liquid classes and subclasses.
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7.3 Liquid Class Optimization
Liquid class optimization for automated assembly of DNA parts is achieved by seri-
ally adjusting available parameters in Aspirate and Dispense liquid class protocols.
The effectiveness of each adjustment in the enzyme liquid 2.0 - 3.5 µL sub-class
was measured by calculating the number of true positive colonies per 100 apparent
positive colonies obtained from blue-white screening of a 20 µL Modular Cloning
(MoClo) [38] DNA assembly reaction creating a constitutively expressed GFP cas-
sette. The strong constitutive promoter J23100, RBS B0032m, GFP gene and double
terminator B0015 DNA parts are inserted into the Kanamycin-resistant destination
vector DVL1 AE. Each parameter test was repeated 8 times.
True positive colonies were calculated by first selecting white colonies from blue-white
screening from a MoClo DNA assembly transformation plate. White colonies were
then both checked for color under UV light followed by DNA sequence verification.
Liquid class optimization of other enzyme sub-classes and the DNA liquid class
were achieved by checking the precision and accuracy of the Aspirate and Dispense
protocols for liquid volumes within the sub-class manually by hand-pipetting. Each
optimization step was repeated 16 times. The efficiency of our protocol (>94%), as
measured by the ratio between positive colony forming units (CFUs) to total number
of CFUs, is equal to that of MoClo reactions prepared manually.
7.3.0.1 Optimized liquid class parameters
Enzymes are generally supplied as viscous liquids often containing 50% glycerol. Op-
timizing liquid class parameters for robotically aspirating and dispensing very small
volumes (2 µL) of enzymes was thus especially challenging. However, we found that
the optimized liquid class for DNA is also sufficient for robotic pipetting of both
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water and enzyme (ligase) buffer. To simplify our protocols, we used the same liquid
class for water, DNA and buffer in our automated DNA assembly protocols. All
parameters were adjusted for single-pipetting only to minimize the risk of contami-
nation. The optimized liquid class parameters for enzyme aspirate and dispense are
listed in Tables 7.1 and 7.3, respectively.
7.3.0.2 Enzyme Liquid Class: Aspirate Protocol Parameters
Liquid Density: 1.131 mg/µL
Table 7.1: Aspirate parameters for enzyme liquid class by volume-based sub-classes
PARAMETER LIQUID SUB-CLASS
2 - 3.5 µL 3.51 - 10 µL 10.1 - 200 µL
Speed 2 µL/s 5 µL/s 50 µL/s
Delay 1000 ms 1000 ms 1000 ms
System Trailing Airgap (STAG) 20 µL 20 µL 20 µL
Leading Airgap (LAG) 10 µL 15 µL 15 µL
Trailing Airgap (TAG) 0 µL 1 µL 1 µL
Excess Volume 0 µL 0 µL 0 µL
Conditioning Volume 0 µL 0 µL 0 µL
Pinch Valve Off Off Off
Liquid Level Detection Off Off Off
Mix before Aspiration No No No
Aspirate Position z-max with -1mm offset (no tracking) z-max with -1 mm offset (no tracking) z-max with -1mm offset (no tracking)
Retract Tips to current position - 5 mm z-dispense - 5 mm current position - 5 mm
Retraction Speed 5 mm/s 5 mm/s 20 mm/s
Modified enzyme liquid class aspirate parameters improving MoClo reac-
tion efficiency for 2-3.5µL subclass
Table 7.2: Stepwise optimization for aspirate protocol for enzyme liquid class.
1Numbers are mean of 8 trials per adjusted parameter. Modified dispense protocol
parameters as found in Table 7.3 were used to dispense samples while testing
aspirate parameter in Table 7.1.
Modified Aspirate Parameter # blue colonies (negative) # white colonies (positive) # true positive/100 white colonies
Aspirate Speed >1000 1 1
Delay >1000 3 3
Aspirate speed + Delay 476 10 9
Aspirate speed + Delay + Aspirate Position 5 312 100
Aspirate Speed: Reducing the aspirate speed from 5µL to 2µL allows sufficient
time for the viscous liquid to get pipetted into the tip.
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Delay: Doubling the delay time (500 ms to 1000 ms) during the aspirate step, and
increasing the dispense delay by 10x (from 200 ms to 2000 ms) allowed sufficient time
for enzymes (50% glycerol) to be aspirated completely resulting in increased MoClo
efficiency. When the delay parameters of both the aspirate and dispense steps were
increased, MoClo reaction efficiency went up from <1% to ∼5%.
Aspirate Position: The quantity of enzyme added to the MoClo reactions is criti-
cal to the overall reaction efficiency. Aspirating from the bottom of the well ensures
that the cloning reaction mix receives a sufficient quantity of enzymes resulting in
an increase in MoClo reaction efficiency from ∼5% to ∼100%.
7.3.0.3 Enzyme Liquid Class: Dispense Protocol Parameters
Liquid Density: 1.131 mg/µL
Table 7.3: Dispense parameters for enzyme liquid class by volume-based sub-classes
PARAMETER LIQUID SUB-CLASS
2 - 3.5 µL 3.51 - 10 µL 10.1 - 200 µL
Speed 5 µL/s 5 µL/s 100 µL/s
Breakoff speed 10 µL/s 10 µL/s 100 µL/s
Delay 2000 ms 2000 ms 2000 ms
Trailing airgap after each dispense No No No
Pinch Valve No No No
Liquid Level Detection Yes Yes Yes
Dispense Position Liquid level detection +1 mm offset (center) Liquid level dection +1 mm offset (center) Liquid level dection +1 mm offset (center)
Tip Touching No No No
Mix after dispense No No No
Retract Tips to Current position -5 mm Current position Current position
Retract Speed 50 mm/s 50 mm/s 50 mm/s
Modified enzyme liquid class dispense parameters that improved accuracy
and precision of dispense protocol for 2-3.5µL subclass
The default, unmodified dispense protocol parameters yielded no positive clones in
MoClo reactions. Dispense protocol parameters were modified prior to making as-
pirate protocol parameter improvements using 50% glycerol followed by manually
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measuring accuracy and precision of dispensed liquid in a series of trials. MoClo
reactions performed using the most precise and accurate dispense protocol param-
eters, but with default aspirate protocol parameters, resulted in no positive clones.
However, using the modified aspirate protocol with the modified dispense protocol
also positive clones in MoClo reactions as found in Table 1.3.
Dispense Speed: Slowing down the dispense step to 0.0125x of the default dispense
speed (from 400 µL/s to 5 µL/s) resulted in MoClo reaction efficiency increasing from
0% to ∼1%.
Breakoff Speed: Breakoff speed is slower to account for high viscosity of enzymes.
Delay: Dispense delay is increased by 10x to provide adequate time for the viscous
enzyme to be dispensed completely.
7.3.0.4 DNA Liquid Class: Aspirate Protocol Parameters
Liquid Density: 1 mg/µL
Table 7.4: Aspirate Parameters for DNA liquid class by volume-based sub-class
PARAMETER LIQUID SUB-CLASS
1.5 - 3.01 µL 3.01 - 5.01 µL 5.01 - 15.01 µL
Speed 2 µL/s 5 µL/s 50 µL/s
Delay 500 ms 500 ms 1000 ms
System Trailing Airgap (STAG) 20 µL 20 L 20 µL
Leading Airgap (LAG) 10 µL 10 µL 15 µL
Trailing Airgap (TAG) 0 µL 0 µL 1 µL
Excess Volume 0 µL 0 µL 0 µL
Conditioning Volume 0 µL 0 µL 0 µL
Pinch Valve Off Off Off
Liquid Level Detection Yes Yes Off
Mix before Aspiration No No No
Aspirate Position Liquid level +1 mm offset (with tracking) Liquid level +1 mm offset (with tracking) z-max with -1mm offset (no tracking)
Retract Tips to current position - 5 mm current position - 5 mm current position - 5 mm
Retraction Speed 20 mm/s 20 mm/s 20 mm/s
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Table 7.5: Dispense Parameters for DNA liquid class by volume-based sub-class
PARAMETER LIQUID SUB-CLASS
1.5 - 3.01 µL 3.01 - 5.01 µL 5.01 - 15.01 µL
Speed 5 µL/s 10 µL/s 10 µL/s
Breakoff speed 10 µL/s 10 µL/s 30 µL/s
Delay 200 ms 200 ms 1000 ms
Trailing airgap after each dispense No No No
Pinch Valve No No No
Liquid Level Detection Yes Yes No
Dispense Position z-max with tracking (no offset) z-max with tracking (no offset) z-max -2 mm offset (no tracking)
Tip Touching No No No
Mix after dispense No No No
Retract Tips to Current position Current position z-dispense
Retract Speed 50 mm/s 50 mm/s 50 mm/s
7.3.0.5 DNA Liquid Class: Dispense Protocol Parameters
7.3.0.6 Adjustable parameters in Tecan Evo Liquid-handling robot Liq-
uid Class Aspirate protocol:
The following are the available parameters of movement and air-displacement of the
disposable pipette tip that can be customized executing aspirate parameters in an
air-displacement Tecan liquid-handling robot. Figure 7.2 provides a screenshot of
the aspirate parameter setup screen within the Freedom EVOware software.
7.4 Experimental validation of optimized liquid classes
The Tecan EVO 150 comes with a single predefined liquid class for pipetting water.
Successful automated DNA assembly requires automated pipetting of water, DNA
enzyme, and enzyme buffer with adequate accuracy and precision allowing correct
clones to be generated with consistency over multiple trials. Since DNA assembly
reactions in synthetic biology are carried out in small volumes, we chose to vali-
date the liquid sub-classes for the lowest volume range functionally, by performing
MoClo DNA assembly reactions. With the limitation that the Tecan EVO 150 can-
not pipette volumes smaller than 2 µL with either precision or accuracy, and being
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Figure 7.2: Screnshot of Aspirate liquid class optimization panel in the Tecan
EVOware software. Parameters must be adjusted for very-small (1.5 - 3.0µL), small
(5.0 - 15.0 µL), mid-range (15.0 - 200 µL) and large (>200 µL) volume ranges for all
liquid with dissimilar viscosity
sensitive to the cost of reagents, we set up 20 µL MoClo reactions such that the min-
imum volume of each reagent being automatically pipetted is 2 µL. Additionally, we
wanted to define the minimum precision and accuracy of automated liquid-handling
that provided DNA assembly efficiency comparable to manual DNA assembly.
7.4.1 Automated DNA Assembly
Using the MoClo DNA assembly instructions generated using Tecan EVOware soft-
ware 7.4.3, 16 MoClo DNA assembly reactions from 16 promoter, 3 RBS, 4 gene, 4
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terminator, and 4 destination vector parts using reagents and reaction setup param-
eters defined in Table 7.6 and shown in Figure 7.3.
We collected the data for the number of positive and true positive colonies from
each of the 16 circuits. 100 assumed positive (white) colonies (or the total number
of available white colonies if there were less than 100 total white colonies) from the
blue-white screening post automated DNA assembly were sequenced to determine if
they were true positives. With the exception of one circuit (circuit 6), where one
white colony was found to have no insert, all sequenced white colonies were found to
be correct. The data can be found in Table 7.7.
7.4.2 Modular Cloning (MoClo) Reaction Parameters and reaction pro-
tocol:
Each of 4 DNA parts (promoter, RBS, gene and terminator) along with destina-
tion vector (DV) were diluted to 10 fmol concentrations and added sequentially, in
equimolar, amounts to the reaction. DNA parts can be purified plasmid DNA, PCR
fragment or synthesized double-stranded DNA. DNA parts were combined with 1x
T4 DNA ligase buffer (Promega), 20 units of the Type IIS restriction endonuclease,
BsaI (New England Biolabs) and 800 units of T4 DNA ligase enzyme (New England
BioLabs). The reaction was brought up to a final volume of 20 µL. The MoClo
reaction setup is shown below in Table 7.6. MoClo reactions were performed in an
Eppendorf Mastercycler ep thermocycler (Eppendorf) using the following parame-
ters: 25 cycles (37◦C for 1.5 minutes, 16◦C for 3 minutes), 50◦C for 5 minutes and
80◦ for 10 minutes. Reactions were then held at 4◦ until transformed.
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Table 7.6: Modular Cloning (MoClo) reaction setup. MoClo DNA assembly
component volumes for a single 20µL MoClo reaction.
Reaction per well
Deionized Water 4 µL
10x Ligase Buffer 2 µL
Promoter (10 fmol) 2 µL
RBS (10 fmol) 2 µL
Gene (10 fmol) 2 µL
Terminator (10 fmol) 2 µL
Destination Vector (10 fmol) 2 µL
BsaI (20 U) 2 µL
T4 DNA Ligase (800 U) 2 µL
TOTAL 20 µL
7.4.3 Automated DNA assembly protocol and setup
Using reagent and DNA part locations on Reagents and DNA source plates respec-
tively, a series of instructions for carrying out the MoClo reactions were generated us-
ing the Tecan EVOware drag-and-drop software. Each MoClo reaction was set up as
described in Table 7.6. The Tecan EVOware instructions file, Automated MoClo.esc
for the assembly is publicly available [18].
Reagents (water, buffer and enzyme) and diluted DNA parts were setup in separate
skirted 96-well PCR plates (See Figure 7.3). The reagent plate was further placed in
an 96-well, iceless, PCR storage cold block (Eppendorf). A third skirted 96-well PCR
plate was used as the destination plate for the final MoClo reactions. All labware
(including the Eppendorf cold block) and labware locations on the Tecan EVO 150
bed were pre-defined in the EVOware protocol prior to executing the DNA assembly
protocol. Locations for waste was also pre-defined prior to executing DNA assembly.
Reagents and DNA parts were aspirated and dispensed into the destination plate
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in the following order: water, buffer, RBS, gene, terminator, destination vector,
promoter, DNA ligase, and BsaI enzyme.
Table 7.7: Positive and True Positive Colony count from automated DNA assembly
by the MoClo assembly method on the Tecan EVO 150 using optimized liquid classes
using automated MoClo reaction setup outlined in Table 7.6.
# total colonies # white colonies (assumed positive) # true positive/100 white colonies
Circuit 1 321 309 100
Circuit 2 290 273 100
Circuit 3 187 178 100
Circuit 4 255 247 100
Circuit 5 417 414 100
Circuit 6 124 77 100
Circuit 7 332 320 99
Circuit 8 210 203 100
Circuit 9 255 249 100
Circuit 10 343 329 100
Circuit 11 198 188 100
Circuit 12 265 249 100
Circuit 13 283 280 100
Circuit 14 184 176 100
Circuit 15 201 189 100
Circuit 16 192 189 100
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Figure 7.3: Setup for Reagent, DNA parts and MoClo reaction plates in
automated DNA assembly. Individual DNA parts from the DNA plate are used
to construct fully assembled transcriptional units in the Destination Plate. (a) Plate
setup: DNA Source Plate contains promoters (columns 1-2), RBSs (column 3), CDSs
(column 4), terminators (column 5) and destination vectors (column 6). Reagent
Plate contains water, 10x ligase buffer, DNA ligase enzyme and Bsa I enzyme in
rows A-D in column 1 respectively. Destination plate shows the final location for
each unique MoClo reaction. The number in each well in the Destination Plate
corresponds to the Level 1 MoClo circuit in Figure 7.3(b). (b) 16 unique Level 1
MoClo circuits built automatically.
Chapter 8
Conclusions and Future Work
Synthetic biology is premised on the principle that genetic parts are modular and
composable. However, the re-composition of genetic parts into devices alters the
DNA sequence at the junctions of genetic parts, thus altering the genetic context
of these parts. Recently the wide variability in expression of promoters [38] and
ribosome binding sites (RBSs) [50] due to fluctuating genetic context has been under
scrutiny. For example, Bicistronic design (BCD) parts that regularize fluctuations
at the promoter:RBS junction by adding a second RBS element translating a short
peptide sequence upstream of the RBS recruiting ribosomes to the gene of interest
are starting to replace traditional RBS parts. These BCD parts are demonstrably
more predictable in their behavior. To further eliminate unexpected circuit behavior
as a result of genetic context effects, we must also consider the general design of
promoter parts used to create synthetic genetic circuits.
8.1 Replacing minimal constitutive promoters with consis-
tent constitutive promoters
This work along with a previous study [38] showed that a number of the minimal
constitutive bacterial promoter parts used in synthetic biology show context depen-
dence when just 1-4 base pairs upstream of the promoter 5’ boundary is altered.
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This context dependence can be eliminated by using screened insulator sequences as
described in this study (see Figure 5.1, Figure 5.2, Figure 5.7 and, Figure 5.8).
One possible method to avoid promoter genetic context effects in a target engineered
genetic circuit would be to evaluate each promoter within the target circuit and eval-
uate whether the promoter is likely to be susceptible to genetic context fluctuations
using the insulation workflows provided here (See Figure 8.1 and Figure 8.3). This
approach has higher cost (see Figure 5.1 and Figure 5.2) in terms of both time and
resources: an insulator screen requires expensive, non-reusable primers and will add
a minimum of 8 days to the build-cycle. A further disadvantage would be that if
insulation is added to a promoter within its final context, no new insulated promoter
parts are generated. If the same promoter needs to be insulated for a different device,
a new promoter screen must be initiated.
A better approach is to convert all commonly used minimal promoters and promot-
ers with RNA polymerase or transcription factor binding sites immediately down-
stream of the 5’ promoter boundaries into reusable promoter parts by screening each
promoter once and then using the screen to determine the DNA sequence of the
spacer/insulator that is incorporated into the promoter. This requires a one-time
insulated promoter library screening investment and generates reusable promoter
parts. To this end, all promoters used in this study are being submitted to Ad-
dgene [1] and the Registry of Standard Biological Parts [35] to share with the larger
synthetic biology community.
Workflows for predicting the need for insulation are not perfect: a preliminary inves-
tigation of the pBAD promoter architecture would lead one to choose to not insulate
promoter pBAD if there was only a single instance of the promoter in a design (See
Figure 8.1. Yet, pBAD is significantly affected by upstream genetic context (see
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Figure 4.7) that is alleviated by insulation.
When the J231XX minimal constitutive promoter series was created, promoter ge-
netic context effects had not been documented, or even anticipated. Before conclusive
evidence on the pervasiveness of genetic context effects caused by fluctuating DNA
sequence at part junctions was available, the standard format for creating synthetic
genetic parts had already been defined as only the stretch of DNA base pairs that
included all necessary features for part function only. DNA bases to insulate parts
against genetic context were not considered a necessary component in genetic part
design. Given the frequency with which promoter genetic context effects are seen
when standard promoter parts are recomposed into engineered genetic circuits, the
current design of promoter parts for bioengineering may be “too minimal”. As in the
case of RBS to BCD design, or RBS to ribozyme+RBS design as better alternatives
to RBS parts, it would be beneficial to amend promoter part design protocols to in-
clude a screened insulator/spacer element as part of general part creation procedure.
8.1.1 Promoter Insulation Workflow
Insulating promoters adds time and supply costs to the process of creating genetic
circuits. Therefore, the decision on whether or not a promoter in a given design
should be insulated or left as is must be carefully evaluated. The decision tree for
evaluating whether or not a given promoter should be insulated is presented in Figure
8.1. The most widely used promoter parts in synthetic biology were designed in a
way that did not include any additional nucleotides adjacent to the promoters’ pro-
tein binding sites - whether RNA Polymerase (RNAP) binding sites or transcription
factor binding sites. When a promoter is fused to a new part, the DNA sequence im-
mediately upstream (5’) of the protein binding sites changes and likely impacts RNA
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polymerase enzyme (in the case of minimal constitutive promoters) or transcription
factor (in the case of regulated promoters) binding in some way that alters promoter
expression. A detailed investigation of the mechanism by which these effects occur
would be illuminating but was beyond the scope of this investigation.
The minimal requirements for executing this decision tree are that there must be an
unambiguous genetic circuit design, and that all promoter parts within this design
have been assigned physical (promoter) part samples with known DNA sequences
for which basic characterization data is available. Each promoter must be evaluated
separately. Once the decision to insulate a promoter part has been made, the specific
steps for insulation follow the workflow outlined in Figure 8.2. The process of primer
design can be automated using a PERL script (See Appendix)
It has been shown that many (but not all) minimal promoters (-35 RNAP binding
site, -10 RNAP binding site and intervening sequences between the -35 and -10
sequences) behave unpredictably when the DNA sequence immediately 5’ of the
promoter boundary is altered [38]. Minimal promoters can be left uninsulated in one
of three cases:
1. If the 4 base pair DNA sequence immediately upstream of the minimal promoter
part in the final device is identical to that of the context in which the promoter
was characterized.
2. If the minimal promoter has been characterized in its final context of DNA
sequence at its 5 boundary and found to behave identically to the version of
itself in its original characterization context.
3. If characterization data for the precise promoter and upstream DNA sequence
in which the promoter is to be recomposed as part of the final circuit design is
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available and is being used in modeling the final device behavior.
However, as has been mentioned above, most minimal promoters are sensitive to
DNA sequence variations immediately upstream of their 5’ boundaries. Therefore,
in the absence of detailed characterization data for the minimal promoter in question
with the precise final context DNA sequence, it will likely save time to simply insulate
minimal promoters as a routine course of action. Thus the insulation workflow for
this step can be simplified by eliminating this decision step (blue diamond) entirely.
For promoters in a design that are not defined as minimal promoters, it must first
be determined based on the promoter architecture whether the 5’ boundary of the
promoter part is directly adjacent to a protein binding site. (Note: minimal promot-
ers are a subset of this type of promoter where there is always a protein binding site
immediately adjacent to the promoter 3’ boundary.) Variations in the DNA sequence
immediately upstream of protein binding sites can alter the kinetics of transcription
factor binding as explained above. Promoters in which transcription factor binding
sites are positioned adjacent to the 5’ promoter boundary are likely to be impacted
by fluctuations in genetic context and should be insulated. However, as in the case
of the repressible pTet promoter, some promoters that fall within this category may
not be impacted by changes in DNA sequence immediately upstream of the promoter
transcription factor binding sites for the specific upstream sequences in a particular
final design. This was the case in my 24 inverter designs, where the pTet promoter
was verified to behave to behave identically regardless of whether MoClo scar A
(5-GGAG-3), E (5GCTT-3), F (5-CGCT-3) or G (5-TGCC-3) scar was placed up-
stream of it. This was determined by characterizing the pTet promoter in isolation
with each upstream scar. As genetic circuits become larger and more complex, insu-
lating promoters that have protein binding sites adjacent to the 5 promoter boundary
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may be a more practical and less time consuming step rather than testing out all
promoters with each specific upstream DNA sequence before deciding to insulate the
promoter. Again, the insulation workflow can be simplified by eliminating this de-
cision point and simply insulating a promoter that is used multiple times, and with
varying upstream DNA sequences, within a design.
Similarly, if multiple instances of a promoter are being used within a single genetic
device, insulating the promoter is likely the only way to guarantee that each instance
behaves identically regardless of where in the device it is placed without resorting to
characterizing the promoter with each upstream DNA sequence.
As such, Figure 8.3 represents the simplified workflow to be followed in deciding
whether to insulate promoters in a given design without having additional charac-
terization steps for promoters from the design in isolation. The simplified workflow is
more in keeping with the the principles of composability that is central to the philis-
ophy of synthetic biology. It also eliminates the need for collecting characterization
data in nonstandardized formats (vector backbones, upstream DNA sequences, an-
tibiotic cassettes).
8.1.1.1 Insulation workflow applied to promoters from 24 inverter per-
mutations
Here I demonstrate the workflow as applied to the three promoters (J23100, pBAD
and pTet) from my 24 inverter permutations. Steps that were not necessary because
of the decisions taken according to the particular promoter are shown in gray. Fig-
ure 8.4 depicts the promoter insulation workflow applied to the minimal constitutive
promoter J23100. Had I not been testing all 24 permutations, I would not have
needed to insulate promoter J23100 as the genetic context (4 bp sequence upstream
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of the 5’ promoter boundary) is the same as that in which the promoter was origi-
nally characterized. However, as I was also making inverters where the J23100 was
positioned elsewhere in the device, I need to insulate it.
Figure 8.5 shows the application of the insulation workflow to promoter pBAD.
Promoter pBAD is used twice in the device with varying genetic context between
the two instances of the promoter. Thus, even in the absence of characterization
data for pBAD A, pBAD , pBAD F and pBAD G, the insulation provides the safest
route to getting equal expression from both instances.
Promoter pTet is an example where the workflow guides us towards insulating a
promoter where it was not strictly necessary. According to the workflow figure
for promoter pTet (Figure 8.6), pTet should be insulated. However, according to
the characterization data for promoter pTet in isolation (pTet A-RFP, pTet E-RFP,
pTet F-RFP, pTet G-RFP), we know that there is no significant difference in ex-
pression when the 4 base pairs upstream of promoter pTet is varied. Insulating pTet
improves performance (in addition to insulating promoters J23100 and pBAD, Fig-
ure 5.8) over insulating just promoters J23100 and pBAD (Figure 6.2.3) but is not
essential to eliminating order dependence.
8.1.2 Applying DNA spacer screening in other organisms
Fluctuating promoter expression as a result of changing DNA sequence at promoter
5’ junctions has been extensively studied in E. coli. However, the problem has
been known to exist in other organisms as well (personal communication, Karmella
Haynes, Arizona State University, Synthetic Biology Engineering Reserch Center
Spring Retreat, 2015). Synthetic promoter parts in other host organisms may also
benefit from insulation against their upstream sequences. Procedurally, there are no
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barriers to transferring the DNA spacer generation and screening methodology to
unidirectional promoter parts in other species of bacteria, as well as in yeast and
even mammalian systems. No modifications to the methodology need to be made.
Insulated promoter libraries can be grown for screening using the standard growth
protocols for flow cytometry for that species and type of promoter. DNA spacers
can be inserted upstream of eukaryotic minimal and other constitutive promoters
in exactly the same way as in the bacterial constitutive promoter (See Figure 5.1).
In mammalian regulated promoters the DNA spacer methodology could serve the
additional purpose of adjusting promoter expression levels without having to change
the locus of cloned regulator elements (such as enhancer or repressor elements), thus
reducing the number of design, build, test cycles. However, the spacer screening
methodology cannot be applied to bidirectional promoters [55, 69]. Bidirectional
promoters are short (<1kb) regions of intergenic DNA between the 5’ ends of two
divergent genes on either strand of DNA. The intergenic region serves as a promoter
element for both genes and adding a spacer of either side of the promoter would
disrupt transcription initiation from the gene on the opposite DNA strand.
8.1.3 Mining DNA spacers for an improved DNA spacer development
process
A detailed analysis of the sequence and structural properties of DNA spacer sequences
was beyond the scope of the project presented in this thesis. Given the immense size
(436) of the theoretical design space of 36 base pair DNA spacers along with the
wide distribution of expression levels observed in each even the small, 200-sample
spacer screens, it appears likely that the DNA spacer sequences obtained through
screening are information-rich and can be mined for connections between specific
137
DNA sequence motifs or secondary structures to a spacer’s impact on promoter
expression. This, in turn, could result in design rules that would allow synthetic
biologists to eventually rationally design DNA spacers rather than having to screen
a library of candidates.
In the absence of a canonical bacterial DNA spacer sequence, any investigation into
sorting screened DNA spacers would necessitate heuristic analyses of much larger
number of candidates. Candidate samples from a DNA spacer library can be sorted
during flow cytometry screening using a cell sorter and divided into a predefined
number of clusters based on expression level relative to promoter expression in its
original characterization context. The entirety of screened candidate spacers would
have to be sequenced, which would likely require deep (Next Generation) sequencing
methods. Samples within each cluster can then be analyzed for common motifs,
secondary structures, DNA looping etc. Conserved commonalities within each cluster
can be formalized into rules for spacer design. These rules would then need to be
tested by testing the ability of rationally designed DNA spacers created using these
rules to precisely and reliably insulate promoters. Once verified, these rules can be
incorporated into bio-design software programs such as EUGENE as a standard step
in the design process for genetic circuits.
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Figure 8.1: Decision process workflow for promoter insulation. The flowchart
depicts the critical decision points in evaluating whether or not a promoter part to
be included in a final design needs to be insulated. A promoter part of known DNA
sequence and position within final device design is the input for the workflow. The
workflow must be executed in its entirety for each promoter part within a genetic
circuit design. Blue decision boxes represent steps that are removed in the simplified
workflow. Green curved rectangles represent terminal decision. Terminal decision is
distinct from output which is either an insulated promoter or the original promoter
left unaltered.
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Figure 8.2: High-level schematic for promoter insulation process. The
flowchart outlines the process for promoter insulation described in Figure 3.2 (Chap-
ter 3). The input (yellow parallelogram) is an uninsulated promoter part. The
output (green parallelogram) is an insulated promoter part. Curved-edge rectangles
represent steps in the protocol. The primer design step can be automated (green
curved-edge rectangle). Purple curved-edge rectangle steps must be performed man-
ually. DNA assembly using the insulated promoter part obtained as the output can
be automated using a liquid-handling robot using Modular Cloning (MoClo) using
protocols described in Chapter 7. PERL script to generate primers is provided in
Chapter 10.
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Figure 8.3: Simplified decision process workflow for promoter insulation.
The flowchart depicts the decision points in evaluating whether or not a promoter
part to be included in a final design needs to be insulated. A promoter part of known
DNA sequence and position within final device design is the input for the workflow.
The workflow must be executed in its entirety for each promoter part within a genetic
circuit design. Blue decision boxes from Figure 8.1 have been removed. Terminal
decision is distinct from output which is either an insulated promomoter or the
original promoter left unaltered.
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Figure 8.4: Promoter insulation protocol applied to constitutive minimal
promoter J23100. The flowchart depicts the decision points that were evaluated
in insulating promoter J23100 from 24 inverter circuits. All decision points that were
not evaluated are shown in gray. Based on both workflow and characterization data
for promoter J23100 (Figure 4.6), I decided to insulate it.
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Figure 8.5: Promoter insulation protocol applied to inducible promoter
pBAD. The flowchart depicts the decision points that were evaluated in insulating
promoter pBAD from 24 inverter circuits. All decision points that were unnecessary
are shown in gray. Based on both workflow and characterization data for promoter
pBAD (Figure 4.7), I decided to insulate it.
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Figure 8.6: Promoter insulation protocol applied to repressible promoter.
The flowchart depicts the decision points that were evaluated in insulating promoter
pTet from 24 inverter circuits. All decision points that were unnecessary are shown
in gray. Based on characterization data for promoter pTet (Figure 4.8), insulating it
was unnecessary.
Chapter 9
Appendix A: 24 Inverter Permutations
Raw Data
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Table 9.1: GFP and RFP expression of uninsulated 24 inverter permuta-
tions upon induction with 1mM L-Arabinose. This table presents the geo-
metric mean of the molecules of equivalent fluorescein (MEFL) for uninsulated 24
inverter set upon induction with L-arabinose for 14 hours. Data graphed in Figure
4.2.
ARABINOSE +
GFP RFP
Device ID Mean
Std. Dev. of
Mean (fold)
Mean
Std.Dev. of
Mean (fold)
Inverter-01 668.89 1.02 160.70 1.10
Inverter-02 621.31 1.01 145.68 1.00
Inverter-03 656.37 1.01 155.71 1.03
Inverter-04 598.06 1.00 143.93 1.00
Inverter-05 2096.02 1.30 14220.90 1.65
Inverter-06 667.62 1.04 298.63 1.14
Inverter-07 728.24 1.01 12803.54 1.65
Inverter-08 735.93 1.00 7683.69 3.01
Inverter-09 1575.55 1.24 1313.00 1.37
Inverter-10 1418.81 2.01 512.99 3.30
Inverter-11 42384.40 1.07 202.64 1.02
Inverter-12 806.84 1.04 9655.75 1.48
Inverter-13 3375.55 1.10 2895.00 1.36
Inverter-14 16814.54 1.40 4131.88 1.21
Inverter-15 10740.46 2.76 2692.28 10.90
Inverter-16 6576.17 3.75 159.16 1.07
Inverter-17 16880.06 1.06 187.97 1.03
Inverter-18 14812.93 1.09 40315.50 1.13
Inverter-19 884.28 1.01 37982.10 1.04
Inverter-20 630.15 1.02 155.31 1.05
Inverter-21 860.93 1.03 42550.53 1.09
Inverter-22 11869.87 1.30 32382.55 1.44
Inverter-23 848.01 1.02 41914.86 1.10
Inverter-24 848.29 1.01 40183.89 1.11
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Table 9.2: GFP and RFP expression of uninsulated 24 inverter permuta-
tions in the absence of induction with 1mM L-Arabinose. This table presents
the geometric mean of the molecules of equivalent fluorescein (MEFL) for uninsu-
lated 24 inverter set in the absence of induction with L-arabinose for 14 hours. Data
graphed in Figure 4.2.
ARABINOSE -
GFP RFP
Device ID Mean
Std.Dev. of
mean (fold)
Mean
Std.Dev. of
mean (fold)
Inverter-01 647.35 1.04 244.17 1.15
Inverter-02 640.91 1.04 156.42 1.08
Inverter-03 683.12 1.14 338.03 2.06
Inverter-04 598.18 1.02 148.42 1.02
Inverter-05 717.68 1.04 16168.21 1.02
Inverter-06 618.15 1.03 534.18 1.16
Inverter-07 599.84 1.01 1396.71 2.72
Inverter-08 587.09 1.02 3528.13 5.53
Inverter-09 641.22 1.05 8158.91 2.41
Inverter-10 699.43 1.22 3456.13 14.60
Inverter-11 4679.83 1.92 267.00 1.31
Inverter-12 682.37 1.10 4577.52 2.92
Inverter-13 741.73 1.09 11264.40 1.34
Inverter-14 746.51 1.04 10596.61 1.81
Inverter-15 1279.69 1.20 4270.28 8.33
Inverter-16 1001.59 1.64 174.58 1.12
Inverter-17 806.32 1.07 174.76 1.03
Inverter-18 2054.68 1.24 47835.69 1.72
Inverter-19 1118.74 1.09 34077.76 1.33
Inverter-20 639.35 1.02 154.28 1.07
Inverter-21 767.88 1.08 39973.21 1.36
Inverter-22 3079.63 1.72 24336.33 1.72
Inverter-23 664.18 1.05 26338.01 1.42
Inverter-24 649.60 1.03 31289.67 1.34
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Table 9.3: GFP and RFP expression of 24 inverter permutations with all
rationally insulated promoters upon induction with 1mM L-Arabinose.
This table presents the geometric mean of the molecules of equivalent fluorescein
(MEFL) for rationally insulated 24 inverter set upon induction with L-arabinose for
14 hours. Data graphed in Figure 4.12.
ARABINOSE +
GFP RFP
Device ID Mean
Std. Dev. of
Mean (fold)
Mean
Std. Dev. of
Mean (fold)
Inverter-01 8764.36 1.25 3316.94 1.40
Inverter-02 6441.78 1.53 2850.53 1.43
Inverter-03 21967.72 1.23 13391.99 1.36
Inverter-04 634.46 1.02 154.03 1.06
Inverter-05 661.84 1.05 147.06 1.01
Inverter-06 721.82 1.05 153.90 1.10
Inverter-07 18375.03 1.18 5495.46 1.35
Inverter-08 19220.16 1.12 12286.44 1.67
Inverter-09 15458.56 1.12 4179.09 1.06
Inverter-10 26292.45 1.13 19629.13 1.01
Inverter-11 21333.94 1.11 3044.67 1.25
Inverter-12 688.46 1.03 174.56 1.03
Inverter-13 3423.62 6.06 1654.74 6.25
Inverter-14 1031.36 5.61 341.85 8.89
Inverter-15 21662.87 1.10 17513.74 1.35
Inverter-16 20280.70 1.23 22495.05 2.04
Inverter-17 3296.64 5.55 5736.26 13.06
Inverter-18 1246.94 1.34 152.88 1.01
Inverter-19 3049.71 9.61 216.13 1.56
Inverter-20 3065.84 1.90 235.97 1.21
Inverter-21 30646.16 1.24 2803.21 1.06
Inverter-22 19274.85 1.05 3323.62 1.11
Inverter-23 1371.63 2.51 204.07 1.28
Inverter-24 1556.73 2.33 187.67 1.17
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Table 9.4: GFP and RFP expression of 24 inverter permutations with all ra-
tionally insulated promoters in the absence of induction with L-arabinose.
This table presents the geometric mean of the molecules of equivalent fluorescein
(MEFL) for rationally insulated 24 inverter set in the absence of induction with
L-arabinose for 14 hours. Data graphed in Figure 4.12.
ARABINOSE -
GFP RFP
Device ID Mean
Std. Dev. of
Mean (fold)
Mean
Std. Dev. of
Mean (fold)
Inverter-01 18819.41 1.30 6655.84 1.38
Inverter-02 2374.86 1.16 8730.66 1.35
Inverter-03 4162.54 1.04 17512.53 1.11
Inverter-04 684.05 1.09 204.79 1.35
Inverter-05 655.06 1.01 154.80 1.03
Inverter-06 664.60 1.05 157.22 1.08
Inverter-07 40602.33 1.07 13149.61 1.14
Inverter-08 3582.53 1.10 19243.72 1.00
Inverter-09 1225.67 1.22 5330.39 1.41
Inverter-10 1688.70 1.04 15660.04 1.10
Inverter-11 2409.97 1.07 7590.28 1.18
Inverter-12 694.62 1.06 194.25 1.16
Inverter-13 1540.33 2.55 2128.25 8.61
Inverter-14 1076.39 1.74 588.72 6.18
Inverter-15 1627.08 1.02 16283.62 1.09
Inverter-16 1308.17 1.16 15240.70 1.38
Inverter-17 1551.53 2.37 4159.03 14.17
Inverter-18 878.91 1.07 166.69 1.10
Inverter-19 2610.13 4.64 240.39 1.51
Inverter-20 1499.63 1.68 312.35 1.08
Inverter-21 35827.71 1.06 6051.78 1.24
Inverter-22 2056.12 1.04 9616.70 1.11
Inverter-23 1042.61 1.57 237.73 1.35
Inverter-24 1310.98 1.70 249.83 1.40
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Table 9.5: GFP and RFP expression of promoter J2300-only insulated 24
inverter permutations upon induction with 1mM L-Arabinose. This table
presents the geometric mean of the molecules of equivalent fluorescein (MEFL) for
promoter J23100-only insulated 24 inverter set in the presence of induction with
L-arabinose for 14 hours. Data graphed in Figure 6.1.
ARABINOSE +
GFP RFP
Device ID Mean
Std. Dev. of
Mean (fold)
Mean
Std. Dev. of
Mean (fold)
Inverter-01 549.54 1.08 6918.31 2.73
Inverter-02 20417.38 2.98 933.25 1.58
Inverter-03 10232.93 1.44 1318.26 1.13
Inverter-04 562.34 1.05 169.82 1.05
Inverter-05 537.03 1.01 165.96 1.02
Inverter-06 562.34 1.02 18620.87 1.03
Inverter-07 537.03 1.02 7585.78 1.30
Inverter-08 22908.68 1.64 1122.02 1.24
Inverter-09 2630.27 1.34 1513.56 1.35
Inverter-10 17782.79 1.07 1737.80 1.29
Inverter-11 30199.52 2.59 977.24 1.30
Inverter-12 575.44 1.04 22387.21 1.14
Inverter-13 13489.63 1.46 912.01 1.12
Inverter-14 13803.84 1.83 1202.26 1.41
Inverter-15 1548.82 1.19 467.74 1.21
Inverter-16 7762.47 2.66 794.33 2.10
Inverter-17 23988.33 1.04 2137.96 1.06
Inverter-18 20892.96 1.05 1659.59 1.25
Inverter-19 602.56 1.05 17378.01 1.06
Inverter-20 67608.30 1.02 3467.37 1.03
Inverter-21 549.54 1.10 19498.45 1.11
Inverter-22 95499.26 1.02 3548.13 1.05
Inverter-23 41686.94 1.06 2818.38 1.03
Inverter-24 38904.51 1.13 2454.71 1.04
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Table 9.6: GFP and RFP expression of promoter J23100-only insulated 24
inverter permutations in the absence of induction with 1mM L-arabinose.
This table presents the geometric mean of the molecules of equivalent fluorescein
(MEFL) for promoter J23100-only insulated 24 inverter set in the absence of induc-
tion with L-arabinose for 14 hours. Data graphed in Figure 6.1.
ARABINOSE -
GFP RFP
Device ID Mean
Std. Dev. of
Mean (fold)
Mean
Std. Dev. of
Mean (fold)
Inverter-01 562.34 1.02 9332.54 4.20
Inverter-02 7079.46 1.13 11220.18 1.15
Inverter-03 1202.26 1.10 19054.61 1.10
Inverter-04 549.54 1.04 218.78 1.27
Inverter-05 537.03 1.02 165.96 1.06
Inverter-06 588.84 1.03 18197.01 1.16
Inverter-07 549.54 1.02 33113.11 1.05
Inverter-08 8511.38 1.20 16218.10 1.10
Inverter-09 741.31 1.09 20417.38 1.05
Inverter-10 1621.81 1.30 31622.78 1.54
Inverter-11 8128.31 1.35 22387.21 1.20
Inverter-12 562.34 1.05 39810.72 1.10
Inverter-13 2238.72 1.13 19054.61 1.08
Inverter-14 2290.87 1.12 12022.64 1.06
Inverter-15 741.31 1.07 28183.83 1.57
Inverter-16 977.24 1.31 40738.03 1.16
Inverter-17 1737.80 1.19 16218.10 1.04
Inverter-18 1698.24 1.29 18620.87 1.23
Inverter-19 588.84 1.05 24547.09 1.15
Inverter-20 3801.89 1.08 18197.01 1.13
Inverter-21 616.60 1.07 32359.37 1.22
Inverter-22 5128.61 1.22 15135.61 1.05
Inverter-23 1445.44 1.39 26302.68 1.27
Inverter-24 3311.31 1.26 14454.40 1.12
151
Table 9.7: GFP and RFP expression of inducible promoter pBAD-only in-
sulated 24 inverter permutations upon induction with 1mM L-Arabinose.
This table presents the geometric mean of the molecules of equivalent fluorescein
(MEFL) for promoter pBAD-only insulated 24 inverter set upon induction with L-
arabinose for 14 hours. Data graphed in Figure 6.2.2.
ARABINOSE +
GFP RFP
Device ID Mean
Std. Dev. of
Mean (fold)
Mean
Std. Dev. of
Mean (fold)
Inverter-01 713.60 1.03 316.76 1.12
Inverter-02 1915.69 1.39 306.23 1.05
Inverter-03 968.61 1.13 336.84 1.11
Inverter-04 4017.92 1.25 389.40 1.06
Inverter-05 3809.23 1.79 602.41 1.32
Inverter-06 6538.00 1.88 754.41 1.17
Inverter-07 31633.19 1.43 541.99 8.63
Inverter-08 14444.48 1.26 22037.89 1.18
Inverter-09 5456.82 1.91 9816.94 3.01
Inverter-10 1468.35 1.16 553.73 1.16
Inverter-11 9366.41 1.09 17803.32 1.31
Inverter-12 1424.60 1.12 482.65 1.03
Inverter-13 2895.20 1.20 23674.35 1.08
Inverter-14 15089.71 1.39 22825.38 1.08
Inverter-15 2369.40 1.23 36665.45 1.02
Inverter-16 1154.81 1.12 770.70 1.15
Inverter-17 17839.55 1.59 24637.46 1.15
Inverter-18 1634.86 1.07 568.47 1.00
Inverter-19 16823.18 1.34 26884.32 1.25
Inverter-20 8868.68 2.09 26416.60 1.07
Inverter-21 1072.51 1.31 433.01 1.43
Inverter-22 26318.07 1.18 18125.54 1.17
Inverter-23 970.42 1.15 369.99 1.20
Inverter-24 17312.59 1.41 22440.68 1.38
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Table 9.8: GFP and RFP expression of inducible promoter pBAD-only
insulated 24 inverter permutations in the absence of induction with 1mM
L-arabinose. This table presents the geometric mean of the molecules of equivalent
fluorescein (MEFL) for promoter pBAD-only insulated 24 inverter set in the absence
of induction with L-arabinose for 14 hours. Data graphed in Figure 6.2.2.
ARABINOSE -
GFP RFP
Device ID Mean
Std. Dev. of
Mean (fold)
Mean
Std. Dev. of
Mean (fold)
Inverter-01 662.68 1.03 281.47 1.08
Inverter-02 762.26 1.03 280.77 1.04
Inverter-03 707.61 1.01 364.82 1.11
Inverter-04 806.23 1.04 454.15 1.15
Inverter-05 831.96 1.11 892.54 1.65
Inverter-06 793.36 1.07 950.71 1.30
Inverter-07 2140.87 1.13 548.83 4.52
Inverter-08 1688.15 1.09 116005.61 1.08
Inverter-09 873.29 1.12 17766.75 3.94
Inverter-10 740.21 1.01 1376.56 1.17
Inverter-11 1156.42 1.00 72212.10 1.59
Inverter-12 795.29 1.08 927.97 1.09
Inverter-13 783.71 1.08 46378.53 2.08
Inverter-14 972.46 1.07 87885.66 1.21
Inverter-15 729.31 1.04 152610.00 1.03
Inverter-16 740.70 1.03 1409.01 1.51
Inverter-17 1001.38 1.01 83134.25 1.04
Inverter-18 806.18 1.04 1052.52 1.11
Inverter-19 995.67 1.05 116439.68 1.36
Inverter-20 886.97 1.04 108697.61 1.23
Inverter-21 668.56 1.01 806.05 1.50
Inverter-22 1333.06 1.10 120009.33 1.12
Inverter-23 664.71 1.04 553.10 1.39
Inverter-24 1247.93 1.04 162992.27 1.07
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Table 9.9: GFP and RFP expression of promoters J23100 and pBAD-
insulated 24 inverter permutations on induction with 1mM L-arabinose.
This table presents the geometric mean of the molecules of equivalent fluorescein
(MEFL) for promoters J23100 and promoter pBAD insulated 24 inverter set upon
induction with L-arabinose for 14 hours. Data graphed in Figure 6.2.3.
ARABINOSE +
GFP RFP
Device ID Mean
Std. Dev. of
Mean (fold)
Mean
Std. Dev. of
Mean (fold)
Inverter-01 6165.9 1.6 4941.2 1.4
Inverter-02 34735.0 1.1 3999.3 1.1
Inverter-03 8064.9 1.6 6356.7 1.3
Inverter-04 37582.4 1.1 3803.3 1.1
Inverter-05 29379.4 1.2 4083.6 1.1
Inverter-06 48585.5 1.1 4407.0 1.4
Inverter-07 15443.8 1.3 5233.0 1.1
Inverter-08 29067.1 1.3 4662.6 1.2
Inverter-09 6831.0 1.2 7535.9 1.0
Inverter-10 25311.0 1.1 9121.1 1.1
Inverter-11 33969.3 1.0 3819.8 1.0
Inverter-12 40980.6 1.1 4546.6 1.2
Inverter-13 17336.9 1.0 5722.0 1.5
Inverter-14 38946.1 1.2 4635.8 1.1
Inverter-15 10186.1 1.5 6903.4 1.4
Inverter-16 23420.2 1.2 7432.5 1.1
Inverter-17 42042.6 1.2 4347.0 1.1
Inverter-18 39023.8 1.1 5695.6 1.1
Inverter-19 45756.4 1.0 6527.6 1.1
Inverter-20 37640.6 1.1 6725.5 1.0
Inverter-21 31329.3 1.1 7391.6 1.2
Inverter-22 29849.1 1.1 5961.6 1.1
Inverter-23 45145.6 1.0 7714.2 1.1
Inverter-24 52253.1 1.1 6728.5 1.3
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Table 9.10: GFP and RFP expression of promoters J23100 and pBAD-
insulated 24 inverter permutations on induction with 1mM L-arabinose.
This table presents the geometric mean of the molecules of equivalent fluorescein
(MEFL) for promoters J23100 and promoter pBAD insulated 24 inverter set in the
absence of induction with L-arabinose for 14 hours. Data graphed in Figure 6.2.3.
ARABINOSE -
GFP RFP
Device ID Mean
Std. Dev. of
Mean (fold)
Mean
Std. Dev. of
Mean (fold)
Inverter-01 1939.4 1.2 42973.4 1.4
Inverter-02 4288.4 1.1 12092.4 1.3
Inverter-03 1817.8 1.2 25232.1 1.1
Inverter-04 3700.4 1.2 14206.0 1.2
Inverter-05 2306.6 1.2 18847.0 1.6
Inverter-06 2982.6 1.2 20486.3 1.7
Inverter-07 3010.0 1.1 50346.2 1.1
Inverter-08 4059.2 1.3 23369.6 1.9
Inverter-09 1209.4 1.1 36526.5 1.6
Inverter-10 2064.3 1.3 41578.0 1.5
Inverter-11 3634.3 1.2 16915.7 1.4
Inverter-12 4493.7 1.4 44726.6 1.4
Inverter-13 2380.1 1.4 22571.8 1.3
Inverter-14 3378.2 1.3 17595.2 1.1
Inverter-15 1551.5 1.1 64704.7 1.3
Inverter-16 2445.0 1.1 61465.6 1.2
Inverter-17 3490.6 1.3 29455.3 1.1
Inverter-18 2215.7 1.3 45977.9 1.5
Inverter-19 2662.4 1.1 40701.4 1.1
Inverter-20 2200.9 1.2 23833.9 1.3
Inverter-21 2099.2 1.2 68742.4 1.2
Inverter-22 4154.3 1.1 17676.8 1.1
Inverter-23 2606.4 1.2 53917.2 1.1
Inverter-24 4158.0 1.2 38753.8 1.3
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Table 9.11: GFP and RFP expression upon induction with 1mM L-
arabinose of the 24 inverter set with all promoters (J23100, pBAD and
pTet) insulated. This table presents the geometric mean of the molecules of equiv-
alent fluorescein (MEFL) for the 24 inverter set with all promoters (J23100, pBAD
and pet) insulated upon induction with L-arabinose for 14 hours. Data graphed in
Figure 6.2.4.
ARABINOSE +
GFP RFP
Device ID Mean
Std. Dev. of
Mean (fold)
Mean
Std. Dev. of
Mean (fold)
Inverter-01 10185.07 1.88 2415.13 1.40
Inverter-02 34500.47 1.19 2070.15 1.31
Inverter-03 17653.51 1.34 221.05 1.48
Inverter-04 49117.25 1.04 1831.23 1.34
Inverter-05 37266.96 1.20 545.61 1.68
Inverter-06 59943.90 1.14 2338.39 1.26
Inverter-07 23243.47 1.06 1711.98 1.21
Inverter-08 39285.29 1.36 1199.51 1.21
Inverter-09 7893.40 1.46 3033.00 1.35
Inverter-10 28017.48 1.35 3781.72 1.25
Inverter-11 39056.02 1.48 1966.13 1.15
Inverter-12 36820.61 1.44 3440.93 1.49
Inverter-13 7906.04 1.08 2743.90 1.17
Inverter-14 29575.22 1.99 1901.21 1.12
Inverter-15 19794.25 1.70 2860.51 1.22
Inverter-16 38507.12 2.94 6992.46 1.53
Inverter-17 37678.19 1.09 2060.98 1.11
Inverter-18 36873.64 1.22 2552.04 1.21
Inverter-19 47606.47 1.11 2399.52 1.35
Inverter-20 35522.54 1.12 2095.72 1.16
Inverter-21 19547.17 1.80 3948.63 1.17
Inverter-22 40723.30 1.22 2623.13 1.36
Inverter-23 61546.59 1.24 4516.01 1.21
Inverter-24 43257.36 1.05 2917.08 1.26
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Table 9.12: GFP and RFP expression upon induction with 1mM L-
arabinose of the 24 inverter set with all promoters (J23100, pBAD and
pTet) insulated. This table presents the geometric mean of the molecules of equiv-
alent fluorescein (MEFL) for the 24 inverter set with all promoters (J23100, pBAD
and pet) insulated in the absence of induction with L-arabinose for 14 hours. Data
graphed in Figure 6.2.4.
ARABINOSE -
GFP RFP
Device ID Mean
Std. Dev. of
Mean (fold)
Mean
Std. Dev. of
Mean (fold)
Inverter-01 2411.89 1.24 14403.73 1.35
Inverter-02 6216.97 1.15 10873.22 1.32
Inverter-03 3443.18 1.04 12738.14 1.50
Inverter-04 2904.28 1.10 11887.90 1.51
Inverter-05 3238.13 1.05 13044.01 1.49
Inverter-06 2519.01 1.07 23115.01 1.42
Inverter-07 2225.88 1.04 23684.65 1.28
Inverter-08 4347.49 1.30 11864.35 1.30
Inverter-09 1975.48 1.17 21472.77 1.37
Inverter-10 1953.31 1.15 20927.77 1.40
Inverter-11 4801.68 1.15 12945.03 1.18
Inverter-12 2980.43 1.11 23395.86 1.27
Inverter-13 2271.85 1.12 18817.94 1.65
Inverter-14 2977.22 1.09 20058.25 1.35
Inverter-15 1823.54 1.10 27262.14 1.17
Inverter-16 1933.86 1.04 42028.80 1.16
Inverter-17 2505.62 1.11 20829.12 1.31
Inverter-18 1987.06 1.11 24220.44 1.46
Inverter-19 2393.75 1.17 19343.59 1.22
Inverter-20 2943.30 1.10 16232.22 1.30
Inverter-21 1833.01 1.04 17184.15 1.53
Inverter-22 3163.14 1.22 14543.00 1.26
Inverter-23 2174.74 1.03 38395.38 1.29
Inverter-24 2697.06 1.21 27161.08 1.68
Chapter 10
Appendix B: PERL Script for DNA
Spacer Primer Design for MoClo-format
promoters
#!/usr/bin/perl
#Swati Banerjee
#Conceived by Douglas Densmore
#Rev 1.0
#9/25/15
#Spacer Primer Generator"
#Minimal error checking
$numArgs = $#ARGV + 1;
if ($numArgs < 6 || $numArgs > 6) {
print "Required format is:\n";
print "-F <FusionSite> -S <Sequence File> -O <Output File>";
}
else
{
foreach $argnum (0 .. $#ARGV) {
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if($ARGV[$argnum-1] eq "-F")
{$fusionSite = $ARGV[$argnum];}
if($ARGV[$argnum-1] eq "-S")
{$sequenceFile = $ARGV[$argnum];}
if($ARGV[$argnum-1] eq "-O")
{$outputFile = $ARGV[$argnum];}
}
print "Running for Fusion Site $fusionSite,
Sequence File $sequenceFile, and Output File
$outputFile \n";
open INFILE, $sequenceFile or die "Couldn’t open file: $!";
$stringSequence = <INFILE>;
close INFILE;
#18 N’s - this is the start of both the forward and reverse primer
$eighteenN = "NNNNNNNNNNNNNNNNNN";
#First 43bp of the sequence -
together with the 18Ns will result in a 61bp
forward primer
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$firstFortyThree = substr($stringSequence, 0, 43);
#Create the forward primer
$forwardPrimer = $eighteenN . $firstFortyThree;
#Get the last 40bp; needed for the reverse primer
$lastForty = substr($stringSequence, -40);
# reverse the DNA sequence
$revcomp40 = reverse($lastForty);
# complement the reversed DNA sequence
$revcomp40 =~ tr/ACGTacgt/TGCAtgca/;
#reverse the fusion site
$revFS = reverse($fusionSite);
$revFS =~ tr/ACGTacgt/TGCAtgca/;
#Create the reverse primer
$reversePrimer = $eighteenN . $revFS . $revcomp40;
$fpPrompt = "Forward Spacer Primer with FS
$fusionSite upstream of promoter:";
$rpPrompt = "Reverse Primer with FS
$fusionSite upstream of promoter:";
open (OUTFILE, ">", $outputFile);
print OUTFILE $fpPrompt;
print OUTFILE "\n";
print OUTFILE $forwardPrimer;
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print OUTFILE "\n\n";
print OUTFILE $rpPrompt;
print OUTFILE "\n";
print OUTFILE $reversePrimer;
print OUTFILE "\n";
close OUTFILE;
}
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